-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, auRUZd23p7fxRoaGbsS/yBfFFGrHO+vKJdY04aHwB+EkKYNM0Gk1NC6r3l/KBJI9 LZDhDJVeBxoBpNW0dapFEQ== 0000950152-94-000163.txt : 19940302 0000950152-94-000163.hdr.sgml : 19940302 ACCESSION NUMBER: 0000950152-94-000163 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 19931130 FILED AS OF DATE: 19940222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENCORP INC CENTRAL INDEX KEY: 0000040888 STANDARD INDUSTRIAL CLASSIFICATION: 3760 IRS NUMBER: 340244000 STATE OF INCORPORATION: OH FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 10-K SEC ACT: 34 SEC FILE NUMBER: 001-01520 FILM NUMBER: 94510974 BUSINESS ADDRESS: STREET 1: 175 GHENT RD CITY: FAIRLAWN STATE: OH ZIP: 44333 BUSINESS PHONE: 2168694200 MAIL ADDRESS: ZIP: ***** FORMER COMPANY: FORMER CONFORMED NAME: GENERAL TIRE & RUBBER CO DATE OF NAME CHANGE: 19840330 10-K 1 GENCORP 10-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended November 30, 1993 Commission File Number 1-1520 GENCORP INC. (Exact name of registrant as specified in its charter) OHIO 34-0244000 (State of Incorporation) (I.R.S. Employer Identification No.) 175 GHENT ROAD, FAIRLAWN, OHIO 44333-3300 (Address of principal executive offices) (Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE (216) 869-4200 SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
NAME OF EACH EXCHANGE TITLE OF EACH CLASS ON WHICH REGISTERED ------------------- --------------------- Common Stock, par value 10c per share New York and Chicago 8% Convertible Subordinated Debentures New York and Chicago due August 1, 2002
SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT: None Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES /X/ NO / / Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. / / The aggregate market value of the voting stock held by nonaffiliates of the registrant as of January 31, 1994, was $458,161,430. As of January 31, 1994, there were 31,729,858 outstanding shares of the Company's Common Stock, 10c par value. DOCUMENTS INCORPORATED BY REFERENCE Portions of the 1994 Proxy Statement of GenCorp Inc. are incorporated into Part III of this Report. 2 GENCORP INC. ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED NOVEMBER 30, 1993 TABLE OF CONTENTS
ITEM PAGE NUMBER NUMBER ------ ------ PART I 1 Business................................................................... 1 2 Properties................................................................. 4 3 Legal Proceedings.......................................................... 5 4 Submission of Matters to a Vote of Security Holders........................ 6 Executive Officers of the Registrant....................................... 6 PART II 5 Market for Registrant's Common Equity and Related Stockholder Matters...... 7 6 Selected Financial Data.................................................... 7 7 Management's Discussion and Analysis of Financial Condition and Results of Operations.................................................... 7 8 Consolidated Financial Statements and Supplementary Data................... 11 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure..................................................... 11 PART III 10 Directors and Executive Officers of the Registrant......................... 32 11 Executive Compensation..................................................... 32 12 Security Ownership of Certain Beneficial Owners and Management............. 32 13 Certain Relationships and Related Transactions............................. 32 PART IV 14 Exhibits, Financial Statement Schedules and Reports on Form 8-K............ 32 Signatures................................................................. 33 Index to Financial Statements and Financial Statement Schedules............ GC-1 Exhibit Index.............................................................. i
3 PART I ITEM 1. BUSINESS GenCorp Inc. (hereinafter the "Company" or "GenCorp") was incorporated in Ohio in 1915 as The General Tire & Rubber Company. The Company's operations are grouped into three business segments: Aerojet-General Corporation ("Aerojet"), GenCorp Automotive and GenCorp Polymer Products. The segments are engaged in such diverse businesses as propulsion, defense electronics, ordnance, molded reinforced plastics, extruded and molded rubber products, vinyl-coated fabrics, plastic films, decorative wallcoverings, tennis balls and racquetballs and styrene and butadiene based specialty latices. The Company currently employs approximately 13,300 persons. (Financial information relating to the Company's business segments appears on pages 26 through 28 of this report.) The Company and its business segments conduct research to develop new products and improve existing products and processes. The Company has a modern, well-equipped Research Center that carries out research in plastics, rubbers, organic coatings, adhesives, polymer processing and engineering analysis for new and improved products. Aerojet maintains additional research and development facilities in the various fields in which it competes. GenCorp Automotive and GenCorp Polymer Products each operate product and process development centers and GenCorp Polymer Products also maintains an innovative design and styling center. (Information relating to research and development expenses is set forth in Note C on page 17 of this report.) The Company licenses technology and owns patents, which expire at various times, relating to many of its products. The loss or expiration of any one or more of them would not materially affect the business of the Company or any of its segments. The important trademarks of the Company are registered in its major marketing areas. Although GenCorp's business is not seasonal in the traditional sense, Aerojet's revenues and earnings have tended to concentrate to some degree in the fourth quarter of each year reflecting delivery schedules associated with that segment's mix of contracts, while GenCorp Automotive's revenues and earnings have tended to concentrate to some degree in the second and fourth quarters of the Company's fiscal year, generally as a consequence of fluctuations in the automotive industry's build schedules and in response to customers' preparation for annual model changes. Compliance with laws and regulations relating to the discharge of materials into the environment or the protection of the environment continues to affect many of the Company's operating facilities. A discussion of capital and noncapital environmental expenditures incurred in 1993 and forecasted for 1994 and 1995 for environmental compliance is included under the heading Environmental Matters on pages 10 and 11 of this report. Environmental matters discussed on pages 10 and 11 and in Note N beginning on page 24 of this report are incorporated herein by reference. AEROJET Aerojet develops, manufactures and markets solid and liquid rocket propulsion systems, ordnance systems and ammunition, sensor surveillance systems and related defense products and services. Aerojet has concentrated for the past several years on obtaining contracts that provide a balance between technology development and long-term production potential, as well as between defense and space programs. More recently, efforts have been expanded to include the pursuit of other domestic and international market opportunities that take advantage of the segment's technologies, engineering and manufacturing expertise and capabilities. In this regard, Aerojet is involved in a series of joint defense-conversion technology initiatives including efforts with Pacific Gas and Electric to apply composite materials technology to liquid natural gas storage applications and a pilot project funded under the Clinton administration's Technology Reinvestment Project program to assess and prototype ultra light insulating material technologies. The segment's largest programs have included the Titan, Peacekeeper, Minuteman, Small ICBM, Advanced Solid Rocket Motor ("ASRM") and Delta propulsion programs; satellite surveillance sensor 4 systems; TOW 2B armaments; Combined Effects Munition systems; and medium caliber ammunition programs. Aerojet is also active in a variety of new development and advanced programs related to defense and space applications including satellite, launch, and armament systems. Aerojet believes that its experience in these areas will enable it to continue to participate in the future funding of such programs. Most of the sales of this segment are made directly or indirectly to agencies of the United States government pursuant to contracts or subcontracts which are subject to termination for convenience (with compensation) by the government in accordance with the Federal Acquisition Regulations. The Small ICBM program was terminated and new production under the Peacekeeper program was canceled during 1992. These two programs accounted for sales of approximately $49 million in 1993. Close-out sales activity in 1994 is anticipated at approximately $20 million. Aerojet is a major subcontractor to Lockheed for the ASRM program. The program was officially terminated by NASA on October 27, 1993. NASA is currently reprogramming to a funding level of $180 million to complete all contractor/subcontractor planned termination activities. Aerojet is now focusing activity on the timely close-out of its subcontract which is expected to be completed by the end of 1995. The ASRM program accounted for Aerojet sales of approximately $118 million in 1993. Aerojet expects approximately $25 million of sales in 1994 related to its termination activity. Aerojet entered into negotiations with Olin Corporation with respect to the sale of substantially all of its medium caliber ammunition and Combined Effects Munition systems business in the fourth quarter of 1993. Negotiations are still in progress as of the date of this report. These ordnance products accounted for sales of approximately $200 million in 1993. Aerojet's direct and indirect sales to the United States Government and its agencies (principally the Department of Defense) were approximately $846 million in 1993, $982 million in 1992 and $1,106 million in 1991. Competition based upon price, technology, quality and service is intense for all products and services in this business segment and has increased with the decline in the national defense budget. There are several other major companies with the technology and capacity to produce most of the products manufactured and sold by Aerojet, and in some areas, the government has its own manufacturing capabilities. With the termination of the ASRM program and the possible sale of a substantial portion of the Ordnance business, Aerojet announced a major streamlining and restructuring effort in the fourth quarter of 1993 that is expected to be completed by mid 1994. Aerojet believes it remains competitive in its markets. Backlog orders in the aerospace and defense businesses are commonplace and significant. Aerojet's contract backlog was approximately $1.4 billion at November 30, 1993, compared to $1.3 billion at November 30, 1992. Funded backlog, which includes only the amount of those contracts for which money has been authorized by Congress, totaled approximately $0.7 billion at November 30, 1993, compared with approximately $0.9 billion at November 30, 1992. Raw materials required by this segment are generally in adequate supply. GENCORP AUTOMOTIVE Revenues of the GenCorp Automotive segment are principally derived from the development, manufacture and sale of highly engineered polymer products developed for the original equipment automotive market. Applications include extruded and molded rubber products for vehicle body and window sealing, molded reinforced plastic panels for automobile and light and heavy truck bodies and molded rubber products for vibration control. The Vehicle Sealing business unit is a leading producer and supplier of extruded and molded rubber products engineered to prevent air and moisture from penetrating windows, doors and other openings. This unit supplies products to all of the major domestic automotive companies for use in a wide variety of vehicles including the General Motors GMT-400 full-size pickup truck, the Suburban GMT 325/330, the Ford Ranger small pickup, the Ford Explorer and the General Motors Achieva, GrandAm and Skylark. 2 5 The Reinforced Plastics business unit is one of the world's largest custom molders of reinforced plastic components for automobile and light and heavy truck bodies. Its state-of-the-art molding facility in Shelbyville, Indiana incorporates innovations in automated manufacturing and is designed for continuous flow manufacturing for the production of reinforced plastic body panels. The plant manufactures body panels for the General Motors Camaro/Firebird and Corvette and for the Chevrolet Lumina, Pontiac TransSport and Oldsmobile Silhouette front wheel drive all-purpose vehicles. General Motors has announced that production of the front wheel drive all-purpose vehicles at its Tarrytown plant will cease in 1996. The Shelbyville facility began producing body panels for the redesigned 1993 model General Motors Camaro/Firebird in the fall of 1992. Additional products manufactured by the Reinforced Plastics unit include roofs for the Chrysler Wrangler Jeep, hoods for the Lincoln Mark VIII, flareside fenders for the Ford F-series and Ranger pickup trucks and hoods for Volvo heavy trucks. In 1993, GenCorp Automotive's Reinforced Plastics unit restructured its manufacturing operations, including the transfer of production lines from the Marion, Indiana facility to the Shelbyville facility. The production facilities at the business unit's Ionia, Michigan facility were also reorganized to focus on heavy truck and other automotive applications. A $21.7 million pre-tax reserve was taken in the fourth quarter of 1992 to cover the anticipated costs of the restructuring. The Vibration Control business unit produces and supplies molded rubber products which counteract the impact and disturbance of vibrations emanating from the power train and from road conditions. These products include bushings, engine mounts and suspension assemblies. This unit supplies products to all of the major domestic automotive companies as well as several foreign vehicle manufacturers. GenCorp Automotive is the sole supplier of many products, including certain vibration control components for the General Motors Lumina, Grand Prix, Regal and Cutlass Supreme, the Chrysler Concord, Dodge Intrepid and Eagle Vision, the Toyota Camry, the Mazda MX6 and 626 and the Ford Probe. During the third quarter of 1993 GenCorp Automotive announced the formation of a strategic alliance which provided GenCorp with a 24.5% equity interest in German automotive supplier HENNIGES Elastomer-und Kunststofftechnik GmbH & Co. KG, and its related companies. The alliance established a European automotive presence for the company. GenCorp Automotive products are sold directly to original equipment manufacturers or their fabricators. GenCorp Automotive customers include the major domestic automobile manufacturers, the loss of one or more of which would have a material adverse effect on this segment. Sales to General Motors in 1993 were at least ten percent of the Company's net sales. The emergence of foreign vehicle manufacturing facilities in North America has significantly changed the original equipment market in recent years. While competition based upon price, quality, service, technology and reputation is increasingly intense with respect to all products marketed by this segment, a strengthening of the automotive market, the successful launch of new product programs and continued improvement in operating efficiencies contributed to improvements in sales and earnings in 1993. Raw materials required by this segment are generally in good supply. GENCORP POLYMER PRODUCTS Revenues of the GenCorp Polymer Products segment are generated through the manufacture and sale of specialty polymers and engineered plastics and elastomers for a variety of industrial, commercial and consumer markets. GenCorp Polymer Products has a broad base of commercial and industrial customers, the loss of any one of which would not have a material adverse effect on the segment's business. The Designed Plastics business unit manufactures and sells decorative and engineered thermoplastic products through three divisions. The Coated Fabrics division is a major supplier of vinyl coated fabrics to the home furnishings and marine industries and to a variety of other industrial and commercial industries. The Plastic Extrusions division produces gaskets, seals, trim and magnetic rolls for the appliance, automotive and office equipment industries. The Building Systems division purchases a full line of elastomer-based single-ply roofing systems for resale to the building products industry for commercial and industrial structures. 3 6 GenCorp Polymer Products formed a new unit, Plastic Films, with the acquisition of Reneer Films Corporation in 1993. The Plastic Films unit is comprised of Reneer Films, the Flexible Film division, and the Rigid Plastics division. Reneer Films produces vinyl woodgrain laminates for furniture and consumer electronics and double-polished clear vinyl films for the office products and stationary markets. The Flexible Film division and the Rigid Plastics division produce decorative and engineered thermoplastic films for manufacturers of furniture, ceiling tiles, credit cards, aircraft interiors, and industrial equipment. The Latex business unit produces and markets a comprehensive line of specialty latices used as coatings for paper, binding agents for carpets and nonwoven fabrics and for tire cord adhesives. It also produces in-mold coatings for automotive reinforced plastic applications. GenCorp Polymer Products has completed construction of a new latex manufacturing facility which adds approximately 80 million dry pounds of annual capacity and enhances manufacturing capabilities. The plant went into operation early in 1993. The new facility augments the segment's business commitment to the coated paper and paper board industry. The Wallcovering business unit designs, manufactures and markets a full line of decorative products for commercial and residential wallcovering applications. The Penn Racquet Sports business unit is one of the world's largest manufacturers of tennis balls and racquetballs. Tennis and racquetball accessories are purchased for resale under the "Penn" name. Previously announced plans to reopen a second tennis ball manufacturing facility in the U.S. have been delayed due to soft demand for tennis products. Methods of distribution utilized by GenCorp Polymer Products vary widely depending on the nature of the products and the industry or market served, with products being sold either directly or through distributors. Penn products are marketed worldwide. The Company has an agreement with Head Racquet Sports to distribute Penn tennis balls in France, Italy and Germany. Competition based upon price, quality, service, technology and reputation is intense with respect to virtually all products marketed by this business segment and, to a substantial degree, upon design and style in the wallcovering and most other coated fabrics and plastic film products. The Company believes that it continues to be a major competitor in the markets served by this segment, and that the raw materials required are generally available. ITEM 2. PROPERTIES The principal operating facilities of the Company and its segments are set forth below. Corporate Headquarters: Segment Headquarters: Westward Look Resort GenCorp Inc. Aerojet Tucson, AZ 175 Ghent Road 1940 Alabama Avenue Fairlawn, Ohio 44333-3300 Rancho Cordova, CA 95741-3530 216/869-4200 916/351-8500 GenCorp Research GenCorp Automotive 2990 Gilchrist Road 350 Springside Drive Akron, OH 44305-4489 Akron, OH 44333-2475 216/794-6300 216/668-7000 GenCorp Polymer Products 350 Springside Drive Akron, OH 44333-2475 216/668-7000
4 7 The Company also has manufacturing, research, design and/or marketing facilities at the locations set forth below.
GENCORP GENCORP AEROJET: AUTOMOTIVE: POLYMER PRODUCTS: -------- ----------- ----------------- Azusa, CA Akron, OH Auburn, PA Mogadore, OH Chino, CA Batesville, AR Columbus, MS Newcomerstown, OH Colorado Springs, CO Berger, MO Dalton, GA Phoenix, AZ Downey, CA Farmington Hills, MI Evansville, IN Pine Brook, NJ Huntsville, AL Ionia, MI Fort Smith, AR Salem, NH Jonesborough, TN Logansport, IN Glen Rock, NJ Mullingar, Los Angeles, CA Marion, IN Green Bay, WI Republic of Ronkonkoma, NY Peru, IN Hackensack, NJ Ireland Sacramento, CA Shelbyville, IN Jeannette, PA Nurnberg, Germany Socorro, NM Wabash, IN Jonesboro, AR Paris, France Washington, DC Welland, Ontario, Canada Maumee, OH
In addition, the Company and its segments own and lease properties (primarily machinery, warehouse and office facilities) in various sections of the country for use in the ordinary course of its business. Data appearing in Note M on page 23 of this report with respect to leased properties is incorporated herein by reference. During 1993, the Company generally made effective use of its productive capacity. As discussed under the heading GenCorp Polymer Products in this report, construction of a new latex manufacturing facility was completed while plans to reopen a second U.S. tennis ball manufacturing facility were delayed. The Company believes that the quality and productive capacity of its properties are sufficient to maintain the Company's competitive position. ITEM 3. LEGAL PROCEEDINGS Effective January 1, 1991, the Company modified its medical benefit plan for salaried employees who had retired. The modifications included increases to retiree-paid deductibles and co-payments, a Medicare "carve-out" provision and an increase in the maximum lifetime benefit. In January 1992, a group of salaried retirees filed a class action challenging the Company's right to implement the benefit plan changes, Dague, et al. v. GenCorp Inc., No. 5:91 CV 2617 (U.S.D.C., N.D. Ohio). On August 27, 1993, the District Court granted summary judgment for GenCorp, holding that the Company had consistently reserved its right within relevant plan documents to modify retiree medical benefits. The ruling rendered moot the retirees' motion for class certification. On August 24, 1993, the retirees appealed the District Court's decision to the U.S. Court of Appeals, where the matter is currently pending, (No. 93-4070, U.S.C.A., 6th Cir.). The Company's annual report on Form 10-K for the fiscal year ended November 30, 1992 discussed the status of the Company's claims against Shearson Lehman Brothers, Inc. ("Shearson") arising out of Shearson's participation in a 1987 hostile tender offer for the Company. On October 2, 1992, the United States District Court in Columbus, Ohio ("Court") granted Shearson's renewed motion for summary judgment on GenCorp's claim for compensatory damages, but granted the Company's renewed motion for clarification of the Court's opinion and order dated April 8, 1992 making it clear that GenCorp's claim for disgorgement of the fees that Shearson received as a result of the takeover attempt was not dismissed and remained in the case. The Court also denied Shearson's renewed motion for summary judgment on GenCorp's claim that Shearson violated a fiduciary duty to GenCorp. Accordingly, judgment was entered in favor of Shearson with respect to GenCorp's claim for compensatory damages, and GenCorp's remaining claim seeking disgorgement to GenCorp of Shearson's fees was stayed pending resolution of an appeal of the judgment on GenCorp's compensatory damages claim to the United States Court of Appeals for the Sixth Circuit. The parties have submitted briefs to the Court, presented oral arguments to the Court and are awaiting decision by the Court. 5 8 Information concerning legal proceedings relating to environmental matters at Aerojet's Sacramento, California facility and at other environmental sites which appears in Note N beginning on page 24 of this report is incorporated herein by reference. The U.S. Government frequently conducts investigations into allegedly illegal or unethical activity in the performance of defense contracts. Investigations of this nature are common to the aerospace and defense industries in which Aerojet participates; possible consequences may include civil and criminal fines and penalties, in some cases, double or treble damages, and suspension or debarment from future government contracting. Aerojet currently is subject to several U.S. Government investigations regarding business practices and cost classification from which legal or administrative proceedings could result. While it is not possible to predict with certainty the outcome of any such investigation, the Company does not believe, based upon the information available at this time, that final resolution of any such matter will have a material adverse effect on its consolidated financial condition or result in its suspension or termination as a government contractor. The Company and its subsidiaries are presently engaged in other litigation, and additional litigation has been threatened. However, based upon information presently available, none of such other litigation is believed to constitute a "material pending legal proceeding" within the meaning of Item 103 of Regulation S-K (17 CFR Reg. 229.103) and the Instructions thereto. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS No matters were submitted to a vote of security holders, through the solicitation of proxies or otherwise, during the quarter ended November 30, 1993. EXECUTIVE OFFICERS OF THE REGISTRANT The following information is given as of February 1, 1994, and except as otherwise indicated, each individual has held the same office during the preceding five-year period. A. W. Reynolds, age 60: Chairman of the Board of Directors (since January 1987) and Chief Executive Officer (since August 1985); formerly President and Chief Operating Officer of the Company (from September 1984 until August 1985). J. B. Yasinsky, age 54: President and Chief Operating Officer (since November 1993); formerly Group President of Westinghouse Electric Corporation (since February 1993), President, Westinghouse Power Systems (from 1990 to 1993), Executive Vice President, Westinghouse, World Resources and Technology (from 1989 to 1990), and Executive Vice President, Westinghouse International, (from 1987 to 1989). W. E. Bachman, age 54: Vice President of the Company and President, GenCorp Polymer Products (since May 1993), formerly Vice President -- Operations for GenCorp Polymer Products (since April 1993), President of the Company's Fabricated Plastics Unit (from 1988 to April 1993) and President of the Coated Fabrics Division (from 1987 to 1988). D. M. Cound, age 62: Vice President -- Quality Management (since June 1992); previously Vice President of Quality for GenCorp Automotive and GenCorp Polymer Products (from 1985 to 1992). E. R. Dye, age 52: Secretary (since September 1988) and Assistant General Counsel (since January 1987); formerly Assistant Secretary (from November 1986 until September 1988), Associate General Counsel (from September 1985 until January 1987) and Counsel prior to September 1985. C. R. Ennis, age 61: Vice President and General Counsel (since January 1986); (also Secretary from November 1986 to September 1988); previously Vice President and General Counsel, International Operations, for subsidiaries of Enserch Corporation. 6 9 G. J. Goberville, age 47: Vice President -- Human Resources (since January 1993); previously Vice President -- Human Resources of GenCorp Automotive (since February 1988), Director of Compensation and Benefits of Aerojet (from 1985 until February 1988). M. L. Isles, age 48: Vice President of the Company and President of GenCorp Automotive (since January 1988); previously President of the Company's former Engineered Elastomers Division. R. A. Livigni, age 59: Vice President and Director of Research (since January 1988); formerly Associate Director -- Research. F. J. Lucksinger, age 48: Vice President and Controller of the Company (since August 1993), previously Vice President, Controller of Aerojet (Vice President since 1989 and Controller since 1987). R. I. Ramseier, age 57: Vice President of the Company and President of Aerojet (since January 1989); formerly President of Aerojet TechSystems. D. M. Steuert, age 45: Vice President and Chief Financial Officer (since June 1990) and Treasurer (since May 1986); previously Vice President -- Finance and Planning (from May 1987 to June 1990) and Treasurer. C. R. Tilden, age 40: Vice President -- Communications (since January 1988); previously Director of Communications for the Company's former DiversiTech General subsidiary (from December 1985 until January 1988). The Company's executive officers generally hold terms of office of one year and/or until their successors are elected. PART II ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS CAPITAL STOCK The common stock is listed on the New York and Chicago Stock Exchanges. At December 31, 1993, there were approximately 15,600 holders of record of the Company's common stock. During 1993, 1992 and 1991, the Company paid quarterly cash dividends on common stock of $.15 per share. Information regarding the high and low quarterly sales prices of common stock for the past two years is contained in the Quarterly Financial Data (unaudited) which appears on page 29 of this report and is incorporated herein by reference. Information concerning long-term debt, including restrictions and provisions relating to distributions and cash dividends on the Company's Common Stock, appears in Note I on page 22 of this report and is incorporated herein by reference. ITEM 6. SELECTED FINANCIAL DATA Financial data required under this section appears on page 30 of this report and is incorporated herein by reference. ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Sales for GenCorp in 1993 were $1.9 billion, 2 percent below the 1992 level while operating profit increased 17 percent to $121 million. Net income of $43 million and primary earnings per share of $1.35 were above 1992 levels of $22 million and $.70, respectively, due to lower interest and corporate expenses and the absence of the 1992 Automotive restructuring charge. Interest expense in 1993 was $36 million compared to $46 million in 1992 and $52 million in 1991. The continued decline in interest expense resulted from lower interest rates and savings from the refinancing activities in 1992. 7 10 Other income and expense increased $9 million to an income of $5 million in 1993 from an expense of $4 million in 1992. The increase was due to the absence of costs associated with the 1992 refinancing effort, adjustments to non-operating reserves and other miscellaneous matters. During 1993, GenCorp acquired Reneer Films which strengthened the Company's position in the plastic film business. The Company also formed a strategic alliance which provides GenCorp with a 24.5 percent equity interest in German automotive supplier, HENNIGES Elastomer- und Kunststofftechnik GmbH & Co. KG. The alliance established a European automotive presence for the Company and offers the potential for future business. Cash flow provided from operating activities for fiscal 1993 was $26 million as compared to $128 million for 1992. Working capital changes included a $63 million payment of tax liabilities related to prior years. The accruals for prior years' taxes provided by the Company were sufficient to cover the full impact of the payment. At November 30, 1993, GenCorp's total debt was $439 million, compared to $345 million for 1992. Debt increased $94 million during 1993 due to the Reneer acquisition, the investment in the HENNIGES strategic alliance and the payment of tax liabilities related to prior years. Capital expenditures were made principally for capacity expansion and asset replacement, cost reduction, safety and productivity improvements and environmental protection. Capital expenditure outlays in 1993 totaled $67 million compared to $96 million in 1992 and $93 million in 1991. Management believes that funds generated from operations and existing borrowing capacity are adequate to finance planned capital expenditures, Company-sponsored research and development programs and dividend payments to shareholders. GENCORP AUTOMOTIVE Sales for GenCorp Automotive during fiscal 1993 were $514 million, an increase of more than 18 percent over 1992 sales of $436 million. The continuing recovery in domestic vehicle production and recent program launches, including the Ford Ranger, Lincoln Mark VIII, Chrysler LH, Camaro and Firebird, were the major contributors to the improvement in sales revenue for each of GenCorp Automotive's business units. Increased sales during 1993 resulted in segment operating profit of $21 million, an increase of $12 million over 1992 excluding a $22 million one-time restructuring charge for Reinforced Plastics in 1992. The Vibration Control and Reinforced Plastics divisions both showed significant earnings improvement. The Vehicle Sealing division offset significant sales price reductions with cost reductions and volume increases to maintain earnings comparable to 1992. Emphasis was placed on increased sales, cost reductions and improved productivity throughout the segment. OUTLOOK Earnings are expected to further improve in 1994, particularly in the Reinforced Plastics division as the division continues to benefit from restructuring efforts and improved operating efficiencies following the F-Car launch in 1993. Sales growth in 1994 will be dependent on the strength of the automotive market and production of key vehicle programs. 1992 RESULTS Sales in 1992 increased 18 percent to $436 million from $368 million in 1991. Excluding a restructuring charge of $22 million for the Reinforced Plastics division, 1992 segment operating profit was $9 million compared to a loss of $5 million in 1991. Including the restructuring charge, the segment incurred an operating loss of $13 million. The significant increase in sales for 1992 was due to increased penetration of key vehicle platforms by GenCorp Automotive and an overall 9 percent growth in the automotive market. The improvement in 8 11 operating profit excluding the restructuring charge was a result of increased sales and continued productivity improvement. AEROJET 1993 sales for Aerojet were $872 million, down 14 percent from 1992 sales of $1,019 million. Sales declines at Aerojet's propulsion and defense electronics businesses accounted for the overall decrease. Sales were affected by the cancellation of the Peacekeeper program, the slowdown in the Titan delivery schedule, lower Strategic Defense Initiative (SDI) and Advanced Solid Rocket Motor (ASRM) funding levels and lower activity in the U.S. Air Force Defense Support Program (DSP) and the U.S. Army Sense and Destroy Armor (SADARM) program. Aerojet segment operating profit was $53 million in 1993, a decrease of 25 percent from $71 million in 1992. The decline in operating profit was due to the decline in sales and contract mix issues. Contract backlog for Aerojet was $1.4 billion at the end of 1993, compared to $1.3 billion and $1.5 billion in 1992 and 1991, respectively. Funded backlog, which includes only the amount of those contracts for which money has been directly authorized by Congress, totaled $0.7 billion at the end of 1993, down from $0.9 billion in 1992 and $1.2 billion in 1991. OUTLOOK 1994 will prove to be another challenging year for Aerojet primarily due to the termination of the ASRM program and the possible sale of the ordnance business. Lower sales and income levels are expected as the continuing reduction of defense budgets affects programs such as Minuteman, SDI and SADARM. Aerojet will continue to face the challenge of maintaining its positions in its core programs within a declining marketplace. To help meet this challenge, compete more effectively and maintain performance expectations on existing programs, Aerojet has initiated a major streamlining and restructuring effort that is expected to be completed by mid-1994. The restructuring should result in substantial reductions in administrative and overhead expenses. 1992 RESULTS Sales in 1992 were $1,019 million, down 11 percent from 1991 sales of $1,142 million. A decline in sales at Aerojet's ordnance business accounted for the overall decrease, primarily due to fewer CEM program deliveries, while the propulsion and defense electronics businesses generated slight increases. Segment operating profit was $71 million in 1992 compared to $75 million in 1991, a decrease of 5 percent. GENCORP POLYMER PRODUCTS GenCorp Polymer Products achieved record sales and segment income levels in 1993. Sales for 1993 were $519 million, an increase of 8 percent over 1992 sales of $482 million. The sales increase was primarily due to market penetration gains in Latex, growth in Wallcovering, strong sales improvements in the Designed Plastics Unit and a significant sales increase in Plastic Films as a result of the acquisition of Reneer Films. These sales gains more than offset the decline in sales for Penn Racquet Sports which was attributable to the weak U.S. tennis market and, to a lesser extent, the recession in Europe. Due to the current softness in the domestic tennis ball market, the previously announced reopening of the tennis ball manufacturing facility in Jonesboro, Arkansas has been delayed. Segment operating profit was $47 million, a 4 percent increase over $45 million in 1992. The earnings improvement was achieved by gains in Designed Plastics, Plastic Films and Wallcovering. However, both Penn Racquet Sports and Latex experienced lower earnings, due to the sales volume decline at Penn and lower profit margins experienced in the paper coatings market for Latex. 9 12 OUTLOOK Steady, reliable growth should continue for GenCorp Polymer Products into 1994. The business will realize the full-year benefits of the Reneer acquisition and a full year of operation at the new latex facility located in Green Bay, Wisconsin. GenCorp Polymer Products maintains strong market positions in each of its businesses and would benefit from improved economic conditions in the United States, especially in the commercial construction and housing sectors. 1992 RESULTS Sales in 1992 of $482 million were essentially equal to 1991's sales of $483 million. Sales improvements in the Wallcovering and Fabricated Plastics divisions were offset by lower sales at Penn Racquet Sports and Latex. Despite the soft economic conditions in the U.S. that adversely affected sales volume, segment operating profit in 1992 reached a record of $45 million or 10 percent higher than the 1991 segment operating profit of $41 million. The improved performance reflected strong market share gains in certain product lines, successful new product introductions and productivity gains throughout the segment. HEALTH CARE COSTS The Company currently provides certain health care and life insurance benefits to most retired employees with varied coverage by employee group. The cost of retiree health care and life insurance benefits is currently recognized as an expense as benefits are paid. The Financial Accounting Standards Board Statement No. 106 "Employers' Accounting for Postretirement Benefits Other Than Pensions" (SFAS 106) requires the Company to account for these costs under the accrual method of accounting beginning in the first quarter of fiscal year 1994. The Company will take a one-time charge against earnings on December 1, 1993 when it implements SFAS 106 (see Note G -- Employee Benefit Plans beginning on page 19 of this report). The SFAS 106 charge reflects the implementation of a new cost-sharing program for retiree medical benefits for former hourly and salaried employees and their spouses. The program establishes limits on the average amount the Company pays annually to provide future retiree medical coverage. The Company believes that it has the legal right to implement this new cost-sharing program and has recently prevailed in a lawsuit before the U. S. District Court challenging the Company's right to modify salaried retiree medical benefits as changed in 1991. This ruling is under appeal to the U.S. Court of Appeals for the Sixth Circuit. While the Company expects to prevail on appeal, an adverse ruling could affect the future cost of providing retiree health benefits. ENVIRONMENTAL MATTERS GenCorp's policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company devotes a significant amount of resources and management attention to environmental matters and actively manages its ongoing processes to comply with extensive environmental laws and regulations. The Company is involved in the remediation of environmental conditions which resulted from previously accepted manufacturing and disposal practices that date back to the 1950s and 1960s at certain of its own plants. In addition, the Company has been designated a potentially responsible party, with other companies, at sites undergoing investigation and remediation. In 1993, capital expenditures for projects related to the environment were approximately $7 million, compared to $10 million in 1992 and $5 million in 1991. The Company currently forecasts that capital expenditures for environmental projects will range between $7 and $8 million in each of the next two years. During 1993, noncapital expenditures for environmental compliance and protection totaled $40 million of which $18 million was for recurring costs associated with managing hazardous substances and pollution in on-going operations and $22 million was for investigation and remediation efforts at other sites. Similar noncapital expenditures were $42 million and $37 million in 1992 and 1991, respectively. It is presently expected that noncapital environmental expenditures will continue at current levels for the next several years. 10 13 The nature of environmental investigation and cleanup activities often makes it difficult to determine the timing and amount of any estimated future costs that may be required for remedial measures. However, the Company reviews these matters and accrues for costs associated with the remediation of environmental pollution when it becomes probable that a liability has been incurred and its proportionate share of the amount can be reasonably estimated. The Company's consolidated balance sheet at November 30, 1993 reflects accruals of $76 million for remediation costs. The effect of resolution of environmental matters on results of operations cannot be predicted due to the uncertainty concerning both the amount and timing of future expenditures and future results of operations. The Company will continue its efforts to mitigate past and future costs through pursuit of claims for insurance and for reimbursement under various government contracts. For additional discussion of environmental matters, refer to Note N, Contingencies and Uncertainties, beginning on page 24 of this report. ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Information called for by this item is set forth beginning on the next page (page 12) of this report. ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE There has been no change in accountants during the Company's two most recent fiscal years or during any period subsequent to the date of the Company's most recent financial statements. 11 14 GENCORP INC. CONSOLIDATED STATEMENT OF INCOME
YEARS ENDED NOVEMBER 30, ---------------------------- 1993 1992 1991 ------ ------ ------ (DOLLARS IN MILLIONS, EXCEPT PER-SHARE DATA) NET SALES........................................................ $1,905 $1,937 $1,993 ------ ------ ------ COSTS AND EXPENSES Cost of products sold............................................ 1,562 1,587 1,660 Selling, general and administrative expense...................... 168 162 165 Depreciation..................................................... 74 79 77 Interest expense................................................. 36 46 52 Other income and expense, net.................................... (5) 4 (10) Restructuring and unusual items.................................. -- 22 -- ------ ------ ------ 1,835 1,900 1,944 ------ ------ ------ INCOME BEFORE INCOME TAXES....................................... 70 37 49 Provision for income taxes (Note D).............................. 27 15 17 ------ ------ ------ Net Income............................................. $ 43 $ 22 $ 32 ====== ====== ====== PER SHARE OF COMMON STOCK Primary.......................................................... $ 1.35 $ .70 $ 1.00 Fully Diluted.................................................... $ 1.24 $ .70 $ 1.00
The accompanying notes to consolidated financial statements are an integral part of these statements. 12 15 GENCORP INC. CONSOLIDATED BALANCE SHEET
AT NOVEMBER 30, ------------------- 1993 1992 ------ ------ (DOLLARS IN MILLIONS) CURRENT ASSETS Cash and equivalents............................................. $ 16 $ 27 Marketable securities, at cost (approximates market)............. 7 7 Accounts receivable (Note E)..................................... 166 156 Inventories (Note F)............................................. 199 200 Prepaid expenses................................................. 42 47 ------ ------ Total Current Assets................................... 430 437 Investments and other assets..................................... 191 155 Property, plant and equipment, at cost Land........................................................... 35 35 Buildings and building equipment............................... 303 300 Machinery and equipment........................................ 925 867 Construction in progress....................................... 36 58 ------ ------ 1,299 1,260 Accumulated depreciation....................................... (756) (721) ------ ------ Net property, plant and equipment........................... 543 539 ------ ------ Total Assets........................................... $1,164 $1,131 ====== ====== CURRENT LIABILITIES Notes payable.................................................... $ 23 $ 1 Accounts payable -- trade........................................ 102 95 Income taxes (Note D)............................................ 14 57 Accrued expenses (Note H)........................................ 202 255 ------ ------ Total Current Liabilities.............................. 341 408 Long-term debt (Note I).......................................... 416 344 Other long-term liabilities...................................... 172 166 Contingencies (Note N) SHAREHOLDERS' EQUITY Preference stock -- $1.00 par value; 15 million shares authorized; none outstanding................................... -- -- Common stock -- $.10 par value; 90 million shares authorized; 31.7 million shares outstanding.................... 3 3 Other capital.................................................... 1 1 Retained earnings................................................ 229 205 Cumulative translation adjustment................................ 2 4 ------ ------ Total Shareholders' Equity............................. 235 213 ------ ------ Total Liabilities and Shareholders' Equity............. $1,164 $1,131 ====== ======
The accompanying notes to consolidated financial statements are an integral part of these statements. 13 16 GENCORP INC. CONSOLIDATED STATEMENT OF CASH FLOWS
YEARS ENDED NOVEMBER 30, ------------------------- 1993 1992 1991 ----- ----- ----- (DOLLARS IN MILLIONS) ------------------------- CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Income from operations............................................. $ 43 $ 22 $ 32 Adjustments to reconcile income from operations to net cash provided by operations: Depreciation, amortization and loss on disposal of fixed assets........................................................ 86 84 79 Changes in Operating Assets and Liabilities Deferred income taxes......................................... (5) (22) 3 Accounts receivable........................................... (13) 13 (22) Inventories................................................... 5 (33) 15 Other current assets.......................................... 5 12 (2) Current liabilities........................................... (93) 29 14 Other long-term liabilities................................... (2) 23 (7) ----- ----- ----- Net Cash Provided by Operating Activities................ 26 128 112 ----- ----- ----- CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES Capital expenditures............................................... (67) (96) (93) Proceeds from asset dispositions................................... 4 1 12 Acquisitions, dispositions and other investments................... (57) (7) (11) Net (increase) decrease in marketable securities................... -- 14 (5) ----- ----- ----- Net Cash Used in Investing Activities.................... (120) (88) (97) ----- ----- ----- CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Long-term debt incurred............................................ 360 416 170 Long-term debt paid................................................ (288) (427) (160) Proceeds from accounts receivable financing........................ 10 -- -- Net short-term debt incurred (paid)................................ 22 -- (1) Dividends.......................................................... (19) (19) (19) Other equity transactions.......................................... (2) (3) -- ----- ----- ----- Net Cash Provided by (Used in) Financing Activities...... 83 (33) (10) ----- ----- ----- NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS............... (11) 7 5 Cash and cash equivalents at beginning of year..................... 27 20 15 ----- ----- ----- Cash and Cash Equivalents at End of Year................. $ 16 $ 27 $ 20 ===== ===== =====
The accompanying notes to consolidated financial statements are an integral part of these statements. 14 17 GENCORP INC. CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
COMMON STOCK CUMULATIVE ------------------- OTHER RETAINED TRANSLATION SHARES AMOUNT CAPITAL EARNINGS ADJUSTMENT ---------- ------ ------- -------- ----------- (DOLLARS IN MILLIONS, EXCEPT PER-SHARE DATA) BALANCE AT NOVEMBER 30, 1990.................... 31,730,858 $ 3 $ 1 $189 $ 7 Net income...................................... 32 Cash dividends -- $.60 per share................ (19) Reacquired shares for incentive programs........ (1,082) -- -- ---------- --- --- ---- --- BALANCE AT NOVEMBER 30, 1991.................... 31,729,776 3 1 202 7 Net income...................................... 22 Currency translation adjustment................. (3) Cash dividends -- $.60 per share................ (19) Reacquired shares for incentive programs........ (571) -- -- ---------- --- --- ---- --- BALANCE AT NOVEMBER 30, 1992.................... 31,729,205 3 1 205 4 Net income...................................... 43 Currency translation adjustment................. (2) Cash dividends -- $.60 per share................ (19) Shares issued under the Management Incentive Plan.......................................... 811 Reacquired shares for incentive programs........ (158) -- -- ---------- --- --- ---- --- BALANCE AT NOVEMBER 30, 1993.................... 31,729,858 $ 3 $ 1 $229 $ 2 ========== === === ==== ===
The accompanying notes to consolidated financial statements are an integral part of these statements. 15 18 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE A -- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES CONSOLIDATION -- The consolidated financial statements of the Company include the accounts of the parent company and its majority-owned subsidiaries. REVENUE RECOGNITION -- Generally, sales are recorded when products are shipped or services are rendered. Sales and income under most government fixed price and fixed price incentive production type contracts are recorded as deliveries are made. For contracts where relatively few deliverable units are produced over a period of more than two years, revenue and income are recognized at the completion of measurable tasks rather than upon delivery of the individual units. Sales under cost reimbursement contracts are recorded as costs are incurred and include estimated earned fees in the proportion that costs incurred to date bear to total estimated costs. Certain government contracts contain cost or performance incentive provisions which provide for increased or decreased fees or profits based upon actual performance against established targets or other criteria. Penalties and cost incentives are considered in estimated sales and profit rates. Performance incentives are recorded when measurable or when awards are made and provisions for estimated losses on contracts are recorded when such losses become evident. ENVIRONMENTAL COSTS -- The Company expenses, on a current basis, recurring costs associated with managing hazardous substances and pollution in ongoing operations. The Company also accrues for costs associated with the remediation of environmental pollution when it becomes probable that a liability has been incurred and its proportionate share of the amount can be reasonably estimated. INVENTORIES -- Inventories are stated at the lower of cost or market. The GenCorp Automotive and GenCorp Polymer Products segments use the last-in, first-out method. The Aerojet segment uses the average cost method. Foreign operations use the first-in, first-out method. Work-in-process on fixed price contracts includes direct costs and overhead less the estimated average cost of deliveries. Appropriate general and administrative costs are allocated to government and certain other contracts. PROPERTY, PLANT AND EQUIPMENT -- Refurbishment costs are capitalized in the property accounts whereas ordinary maintenance and repair costs are expensed as incurred. Gains or losses from disposals are reflected in income. Depreciation for financial reporting is computed principally by accelerated methods for the Aerojet segment and by the straight-line method for the remainder of the Company. GOODWILL -- The excess of purchase price over the value of net assets acquired is included in other assets and is amortized generally on a straight-line basis over a 40-year period or less. INCOME TAXES -- Deferred income taxes are provided for timing differences between financial statement and taxable income. HEDGING INSTRUMENTS -- The Company periodically enters into interest rate swap agreements in the management of interest rate exposure. The differential to be paid is accrued as interest rates change and is recognized over the life of the agreements. The notional amounts of swap agreements are matched with a related underlying liability and as such are not subject to lower of cost or market value accounting. STATEMENT OF CASH FLOWS -- For the purposes of the statement of cash flows, all highly liquid debt instruments purchased with a maturity of three months or less are considered to be cash equivalents. EARNINGS PER SHARE -- Primary earnings per share of common stock is calculated by dividing net income by the weighted average number of common shares outstanding. For fully diluted earnings per share, both net income and shares outstanding have been adjusted as if the Company's $115,000,000 8% Convertible Subordinated Debentures due August 1, 2002 had been converted. (See Note I on page 22 of this report for further information regarding the debentures.) 16 19 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED NOTE B -- ACQUISITIONS RENEER FILMS CORPORATION On July 19, 1993, the Company purchased Reneer Films Corporation from Goodyear Tire & Rubber Company for approximately $26 million. Reneer Films' principal business is the manufacture and distribution of vinyl woodgrain laminates for furniture and consumer electronics and clear plastic films. The acquisition was accounted for as a purchase in accordance with Accounting Principles Board Opinion No. 16 and accordingly, the operating results have been included in the Company's financial results since the date of acquisition. The acquisition cost approximated the fair value of assets acquired. HENNIGES ELASTOMER-UND KUNSTSTOFFTECHNIK GMBH & CO. KG On July 21, 1993, the Company purchased a 24.5 percent interest in HENNIGES Elastomer- und Kunststofftechnik GmbH & Co. KG (HEK) and its related companies for approximately $18 million. HEK's principal business is the manufacture and distribution of engineered molded and extruded rubber products for the major German original equipment automotive manufacturers. The investment is accounted for by the equity method. The acquisition agreement grants the seller the option to require GenCorp to purchase all remaining interest in HEK and grants GenCorp the option to acquire all remaining interest in HEK at stated intervals through 2003. The purchase price of the remaining interest in HEK will be determined by a performance related formula set forth in the acquisition agreement. NOTE C -- RESEARCH AND DEVELOPMENT EXPENSE Research and Development (R&D) expense was $45 million in 1993 and $36 million in 1992 and 1991. R&D expense includes the costs of technical activities that are useful in developing new products, services, processes or techniques, as well as those expenses that may significantly improve existing products or processes. Additional R&D expenditures which are funded under government contracts totaled $112 million in 1993, $166 million in 1992 and $174 million in 1991. NOTE D -- INCOME TAXES The provision for income taxes consists of the following:
YEARS ENDED NOVEMBER 30, -------------------------- 1993 1992 1991 ---- ---- ---- (DOLLARS IN MILLIONS) CURRENT TAXES U.S. federal................................................ $16 $15 $13 State and local............................................. 6 4 7 Foreign..................................................... 8 6 3 --- --- --- 30 25 23 DEFERRED TAXES U.S. federal................................................ -- (9) (3) State and local............................................. (3) (1) (3) --- --- --- Total provision for income taxes.................. $27 $15 $17 === === ===
17 20 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED The change in deferred income taxes reflects the tax effects of the following items recognized as revenue or expense in different years for tax and financial statement purposes:
YEARS ENDED NOVEMBER 30, -------------------------------- 1993 1992 1991 ---- ---- ---- (DOLLARS IN MILLIONS) Long-term contracts................................. $ (4) $ -- $ (4) Depreciation expense................................ -- (7) 1 Pension expense..................................... 4 2 3 Accrued estimated costs............................. 7 (7) 7 Prefunded employee health benefits.................. -- -- (3) Other, net.......................................... (10) 2 (10) ---- ---- ---- $ (3) $(10) $ (6) ==== ==== ====
The difference between the statutory federal income tax rate and the effective tax rate is attributable to the following:
YEARS ENDED NOVEMBER 30, -------------------------------- 1993 1992 1991 ---- ---- ---- Statutory income tax rate............................ 34.9% 34.0% 34.0% State and local income taxes, net of federal income tax benefit........................................ 2.1 6.9 5.3 Change in tax rate on deferred tax reversals......... .4 .8 (.2) Earnings of subsidiaries taxed at other than U.S. statutory rate..................................... 2.0 1.7 (.5) Benefit of tax loss on sale/liquidation of foreign subsidiaries....................................... -- -- (3.6) Other, net........................................... (.9) (2.3) .4 ---- ---- ---- Effective income tax rate.................. 38.5% 41.1% 35.4% ==== ==== ====
The balance sheet reflects deferred income taxes of $37 million and $38 million in prepaid expenses at November 30, 1993 and 1992, respectively. Included in other long-term assets for 1993 and 1992 are deferred income taxes of $13 million and $9 million, respectively. Pretax income of foreign subsidiaries was $18 million in 1993, $25 million in 1992 and $12 million in 1991. Cash paid during the year for income taxes was $79 million in 1993, $25 million in 1992 and $14 million in 1991. The Company presently follows the provisions of Accounting Principles Board Opinion No. 11 "Accounting for Income Taxes" (APB 11) to account for income taxes. In February 1992, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 109 "Accounting for Income Taxes" (SFAS 109) which supersedes APB 11. Adoption by the Company will be required by fiscal year 1994. The recognition and measurement of deferred tax assets and liabilities differs significantly under SFAS 109 and APB 11. Under SFAS 109, the liability method is used in accounting for income taxes, whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Under APB 11, income tax expense is determined using the deferred method. Deferred tax expense is based on items of income and expense that are reported in different years in the financial statements and tax returns and are measured at the tax rate in effect in the year the difference originated. The Company will implement SFAS 109 in the first quarter of 1994 as a cumulative effect of a change in accounting for income taxes. Application of the new standard will reduce equity by approximately $12 million. 18 21 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED NOTE E -- ACCOUNTS RECEIVABLE In June 1993, the Company extended its agreement with a financial institution to sell, with limited recourse, $60 million of undivided fractional interests in a pool of approximately $100 million of eligible accounts receivable through June 1994. This represents a $10 million increase from the prior agreement. Under the agreement, new receivables are sold as collections reduce previously sold receivables. The Company has retained collection and administrative responsibilities as agent for the purchaser and has established an allowance for doubtful accounts for such receivables based on expected collectibility. Accounts receivable as shown in the Consolidated Balance Sheet at November 30, 1993 and 1992 are net of $60 million and $50 million, respectively, representing the interests in receivables sold under this agreement. Unbilled receivables of $9 million and $16 million at November 30, 1993 and 1992, respectively, relating to long-term government contracts are included in accounts receivable from the U.S. Government. Such amounts are billed either upon delivery of completed units or settlement of contracts. The unbilled receivables amount at November 30, 1993 includes $2 million expected to be collected in fiscal year 1994, and $7 million expected to be collected in subsequent years. At year end, the amount of commercial and U.S. government receivables were $88 million and $78 million for 1993 and $92 million and $64 million for 1992, respectively. NOTE F -- INVENTORIES Components of inventories are as follows:
AT NOVEMBER 30, ------------------ 1993 1992 ---- ---- (DOLLARS IN MILLIONS) Raw materials and supplies..................................... $ 44 $ 37 Work-in-process................................................ 15 15 Finished products.............................................. 57 53 ---- ---- Approximate replacement cost of inventories.................... 116 105 Reserves, primarily LIFO....................................... (35) (35) Long-term contracts at average cost............................ 262 293 Progress payments.............................................. (144) (163) ---- ---- $199 $200 ==== ====
Aerojet segment inventories applicable to government and other contracts include general and administrative costs. The total of such costs incurred in 1993 and 1992 was $127 million and $130 million, respectively, and the amounts in inventory at the end of those years are estimated at $27 million and $37 million, respectively. These estimates are based on costs being removed from inventories on a basis proportional to the amounts of each cost element projected through completion of the contract. Inventories using the LIFO method represented 78 percent of consolidated inventories at replacement cost at November 30, 1993 and 1992. NOTE G -- EMPLOYEE BENEFIT PLANS The Company has a number of defined benefit pension plans which cover substantially all salaried and hourly employees. Normal retirement age generally is 65, but certain plan provisions allow for earlier retirement. The Company's funding policy is consistent with the funding requirements of federal law. The pension plans provide for pension benefits, the amounts of which are calculated under formulas principally 19 22 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED based on average earnings and length of service for salaried employees and under negotiated non-wage based formulas for hourly employees. The components of net pension costs (income) are as follows:
YEARS ENDED NOVEMBER 30, ---------------------- 1993 1992 1991 ---- ---- ---- (DOLLARS IN MILLIONS) Service cost -- benefits earned during the period........... $ 20 $ 22 $ 22 Interest cost on projected benefit obligation............... 111 106 97 Actual return on assets..................................... (231) (170) (214) Net amortization and deferral............................... 93 38 92 ---- ---- ---- Net pension costs (income).................................. $ (7) $ (4) $ (3) ==== ==== ====
The assumptions used in calculating the present value of the accrued defined benefit pension plan benefits and pension cost at November 30, 1993, 1992 and 1991 and for the years then ended were determined in consultation with the Company's actuary. Excluding a variable annuity program with an interest assumption of 8 percent and assets at November 30, 1993 of $730 million, the weighted average expected rate of return on plan assets for all plans was 9 percent for all years presented. The assumed discount rate was 8 percent and the assumed rate of increase in salaried compensation levels was 5 percent in all years presented. Benefits under the hourly plans are not based on wages. Therefore, no benefit escalation assumption beyond negotiated increases is provided. During 1993, the Company modified its turnover assumption to reflect past and anticipated future experience. This change decreased 1993 pension cost by $5 million. There was no material impact on the projected benefit obligation. The majority of the Company's plan assets are invested in short-term investments, listed stocks and bonds. THE FOLLOWING TABLE PRESENTS THE FUNDED STATUS OF THE PLANS:
AT NOVEMBER 30, ----------------- 1993 1992 ------ ------ (DOLLARS IN MILLIONS) Plan assets at fair value.......................................... $1,757 $1,613 ------ ------ Actuarial present value of plan benefits: Vested........................................................... $1,398 $1,331 Non-vested....................................................... 73 42 ------ ------ Accumulated benefit obligation..................................... 1,471 1,373 Effect of projected salary increases............................... 49 58 ------ ------ Projected benefit obligation....................................... $1,520 $1,431 ------ ------ Overfunded plans................................................... $ 237 $ 182 Unamortized balances: Transition asset................................................. (39) (43) Plan amendments.................................................. 26 22 Experience gains................................................. (126) (70) ------ ------ Prepaid pension cost (included in investments and other assets)................................................ $ 98 $ 91 ====== ======
The Company also sponsors a number of defined contribution pension plans. Participation in one of these plans is available to substantially all salaried employees and to certain groups of hourly employees. Company contributions to these plans are based on either a percentage of employee contributions or on a specified 20 23 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED amount per hour based on the provisions of each plan. The cost of these plans was $14 million in 1993, $15 million in 1992 and $14 million in 1991. In addition to providing pension benefits, the Company currently provides certain health care and life insurance benefits to most retired employees with varied coverage by employee group. The cost of retiree health care and life insurance benefits is currently recognized as an expense as benefits are paid. These pretax costs totaled $21 million in 1993, $20 million in 1992 and $18 million in 1991. The Financial Accounting Standards Board Statement No. 106 "Employers' Accounting for Postretirement Benefits Other Than Pensions" (SFAS 106) requires the Company to account for these costs under the accrual method of accounting. The Company will take a one-time charge against earnings on December 1, 1993 when it implements SFAS 106. The Company's after-tax charge for postretirement benefits will be $196 million, compared to the previously disclosed range of $280 to $385 million. This after-tax charge includes the impact of the recent cost-sharing program announced to employees and retirees in 1993. The Company expects that its 1994 after-tax expense for postretirement benefits should approximate projected cash expenditures for the same period. Any increase in expense is expected to range between zero and $4 million as compared to the previously disclosed estimated range of $13 to $44 million. In November 1992, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 112 "Employers' Accounting for Postemployment Benefits". The standard, which must be adopted by 1995, requires postemployment benefits such as workers' compensation and supplemental unemployment benefits to be accounted for on the accrual basis rather than the cash basis. The Company currently uses the accrual method for most of these benefits and, therefore, does not anticipate that the adoption of this standard will have a material impact on the Company's reported financial condition or results of operations. NOTE H -- ACCRUED EXPENSES The components of accrued expenses are as follows:
AT NOVEMBER 30, ------------------ 1993 1992 ---- ---- (DOLLARS IN MILLIONS) Payable for goods, services and rights........................... $110 $143 Accrued compensation and employee benefits....................... 48 50 Restructuring and other reserves................................. 25 30 Accrued expenses -- other........................................ 19 32 ---- ---- $202 $255 ==== ====
21 24 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED NOTE I -- LONG-TERM DEBT AND CREDIT LINES Long-term debt consists of the following:
AT NOVEMBER 30, ------------------ 1993 1992 ---- ---- (DOLLARS IN MILLIONS) Revolving loans.................................................. $300 $225 8% Unsecured convertible subordinated debentures maturing 2002... 115 115 Other............................................................ 3 5 ---- ---- Total debt....................................................... 418 345 Less amounts due within one year................................. (2) (1) ---- ---- $416 $344 ==== ====
On April 1, 1992, the Company entered into a three-year $450 million unsecured revolving credit facility. Unused revolving lines of credit currently aggregate $150 million. The Company pays commitment fees of 3/8 of one percent on the unused balance. Interest rates are variable, primarily based on LIBOR, and are currently at an average rate of 4.3 percent. The revolving loan contains various debt restrictions and provisions relating to net worth and interest coverage ratios. The Company is required to maintain consolidated net worth of not less than $222 million excluding the impact of the implementation of new accounting standards. The revolving loan expires April 1995 and is extendable for up to two additional years at the option of the Company and with the approval of the banks. The Company has interest rate swap agreements covering a notional amount of $75 million, which expire in 1995. The semi-annual settlement rates for these agreements are calculated as a spread between a fixed annual rate of 9.5 percent and the six month floating LIBOR rate. During the third quarter of 1992, the Company issued $115 million of 8% Convertible Subordinated Debentures due August 1, 2002 (Debentures). The Debentures are redeemable at the option of the Company, in whole or in part, at any time on or after August 10, 1996. The Debentures are convertible at any time prior to maturity, unless previously redeemed, into shares of Common Stock at a conversion price of $16.065 per share (equivalent to a conversion rate of approximately 62.247 shares of Common Stock per $1,000 principal amount of Debentures) subject to adjustment in certain circumstances. The quoted market value of the Debentures was $129 million at November 30, 1993. At November 30, 1993, the Company had borrowed $22 million of its $25 million unsecured, uncommitted lines of credit with several banks for short-term borrowings. Borrowings under such lines generally bear interest at money market rates and are payable on demand. The Company also had outstanding letters of credit of $47 million at November 30, 1993. Cash paid during the year for interest was $28 million in 1993, $33 million in 1992 and $41 million in 1991. Interest expense in 1993, 1992 and 1991 includes imputed interest of $9 million in each year on the present value of the postretirement benefit liability established in conjunction with the sale of a discontinued operation. NOTE J -- DISCONTINUED OPERATIONS The balance sheet includes various current and long-term reserves relating to operations discontinued in prior years. Those reserves include estimates for postretirement benefits (General Tire), environmental matters (Lawrence, MA and Muskegon, MI) and other accrued liabilities (RKO General). The reserves for discontinued operations were $30 million and $26 million of current liabilities and $96 million and $107 million of other long-term liabilities as of November 30, 1993 and 1992, respectively. 22 25 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED NOTE K -- PREFERRED SHARE PURCHASE RIGHTS In 1987, the Directors declared a dividend of one Preferred Share Purchase Right (Right) on each outstanding share of common stock, payable to shareholders of record on February 27, 1987. Rights outstanding at November 30, 1993 and 1992 were 31,729,858 and 31,729,205, respectively. The Shareholder Rights Plan, as amended effective December 1987, provides that under certain circumstances each Right will entitle shareholders to buy one one-hundredth of a share of a new Series A Cumulative Preference Stock at an exercise price of $100. The Rights will be exercisable only if a person or group acquires 20 percent or more of GenCorp's common stock or announces a tender or exchange offer that will result in such person or group acquiring 30 percent or more of the common stock. GenCorp will be entitled to redeem the Rights at two cents per Right at any time until ten days after a 20 percent position has been acquired (unless the Board elects to extend such time period, which in no event may exceed thirty days). If the Company is involved in certain transactions after the Rights become exercisable, a holder of Rights (other than Rights beneficially owned by a shareholder who has acquired 20 percent or more of GenCorp's common stock, which Rights become void) is entitled to buy a number of the acquiring company's common shares, or GenCorp's common stock, as the case may be, having a market value of twice the exercise price of each Right. A potential dilutive effect may exist upon the exercise of the Rights. The Rights will expire February 18, 1997. Until a Right is exercised, the holder will have no rights as a stockholder of the Company including, without limitation, the right to vote as a stockholder or to receive dividends. Effective November 25, 1987, the Board authorized a reserve of 325,000 shares of $1 par value Series A Cumulative Preference Stock for issuance upon exercise of Preferred Share Purchase Rights. NOTE L -- LONG-TERM COMPENSATION PLANS The GenCorp Inc. 1993 Stock Option Plan provides for an aggregate of 2,500,000 shares of the Company's common stock to be purchased pursuant to stock options or to be subject to stock appreciation rights (SARs) which may be granted to selected officers and key employees at prices equal to the market value of a share of common stock on the date of grant. In 1993, the Company granted options to purchase 501,575 shares of common stock at purchase prices ranging from $16.00 per share to $16.625 per share. The options are exercisable in 25 percent increments at six months, one year, two years and three years from date of grant. None of the options are exercisable prior to March 10, 1994. No stock appreciation rights have been granted. Shares available for future grant were 2,003,925 at November 30, 1993, including 5,500 shares from forfeited options. The Stock Incentive Compensation Plan (SIC Plan) adopted in 1983 is based on a formula which values incentive awards payable in cash or stock based upon changes in the market value of the Company's common stock. The SIC Plan is compensatory, and compensation expense was $5 million in 1993 and $3 million in 1992 and 1991. The liability for accrued stock incentive compensation was $15 million and $12 million at November 30, 1993 and 1992, respectively. Pursuant to the SIC Plan, no awards may be granted after March 1, 1993 and the Company granted no incentive unit shares during 1993. The Company granted 443,000 incentive unit shares during 1992 and 383,000 during 1991. NOTE M -- LEASE COMMITMENTS The Company and its subsidiaries lease certain manufacturing plant facilities, machinery and equipment and office buildings under long-term, noncancelable leases. The leases generally provide for renewal options ranging from five to ten years and require the Company to pay for utilities, insurance, taxes and maintenance. Rent expense was $14 million in 1993, $15 million in 1992 and $17 million in 1991. Future minimum commitments at November 30, 1993 for existing operating leases were $39 million with annual amounts declining from $9 million in 1994 to $3 million in 1998. The Company's current obligation for leases after 1998 is $7 million. 23 26 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED NOTE N -- CONTINGENCIES AND UNCERTAINTIES ENVIRONMENTAL MATTERS Sacramento, California -- In June 1989, the United States District Court for the Eastern District of California approved entry of a Partial Consent Decree (Decree) which partially settled environmental litigation initiated against Aerojet and its inactive subsidiary, Cordova Chemical Company, by the State of California (State) and the United States Environmental Protection Agency (EPA) as a result of the release of chemicals at Aerojet's Sacramento, California facility prior to 1980. Aerojet is conducting a Remedial Investigation/Feasibility Study (RI/FS) of the Sacramento site under the Decree and will prepare an RI/FS report on specific environmental conditions present at the site and alternatives available to remedy such conditions. The Decree does not require Aerojet to perform final remedial measures at the site. The Decree provides that, during the period 1989 through 1994, Aerojet will pay an aggregate of $5.4 million to (i) resolve civil monetary claims of the State and (ii) reimburse the State and the EPA for their past costs incurred in connection with the environmental matters at the Sacramento site. Aerojet has paid $4.8 million through November 30, 1993 toward this obligation. Additionally, Aerojet is required to pay for certain costs associated with government monitoring of Aerojet's compliance with the Decree. In 1990, the United States government settled Aerojet's claims for reimbursement of a portion of environmental costs incurred at the site prior to July 1989 for $37 million. The 1990 settlement requires that the United States will receive credit equal to 50 percent of any insurance recovery that Aerojet may receive in respect of costs covered by the settlement, except amounts paid conditionally or under a reservation of the insurers' rights or claims. In September 1993, Aerojet reached a second settlement with the United States government on its claim to recover a portion of environmental restoration costs incurred, or to be incurred, after June 1989 ("covered costs"). Under the terms of the 1993 settlement, covered costs recovered by Aerojet for the period July 1989 through November 1992 total approximately $18 million. This recovery was accomplished through the government's release of rights to funds held by Aerojet. The settlement also provides that 65 percent of covered costs incurred after November 1992, net of insurance recoveries, will be added to the pricing of government contracts. As in the case of the first settlement, Aerojet agreed to dismiss its contract claim before the Armed Services Board of Contract Appeals and also to release its claim under the "Superfund" law against the United States in federal district court for recovery of costs covered by the settlement. Prior to the 1993 settlement, Aerojet recognized for accounting purposes an expected minimum recovery from the United States government for 50 percent of covered costs incurred after June 1989. Aerojet assessed that a recovery was probable based on both the 1990 settlement and then current negotiations regarding a second settlement. Accordingly, $9 million of the $18 million recovered in September reduced a receivable. In addition, as a result of knowledge obtained in the continuing RI/FS process, Aerojet recorded a $9 million reserve in the fourth quarter of 1993 for its share of the currently identifiable remediation costs. Aerojet is in the process of completing the RI/FS which is designed to determine the extent of the contamination and feasible remediation efforts. Aerojet has a reserve of approximately $22 million, including the $9 million reserve described above, for its expected share of future environmental costs to complete the RI/FS and for currently identifiable remediation. However, until the RI/FS process is substantially completed, Aerojet will not be able to determine the ultimate costs or the duration of time for the final remediation effort. 24 27 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED Legal proceedings to obtain reimbursement of environmental response costs from insurers are continuing. However, Aerojet presently cannot estimate either the total amount of such costs that may be incurred at the site or the recovery that may be obtained under any policy. Lawrence, Massachusetts -- The Company has completed a study of remediation alternatives for its closed Lawrence, Massachusetts facility, which was contaminated with PCBs, and has begun site remediation and off-site disposal of debris. A reserve of $32 million has been provided for the decontamination and the long-term operating and maintenance costs of this site. The reserve represents the Company's best estimate at present for the eventual remediation cost. The study indicated that the remediation cost could range as high as $56 million depending on the results of future testing and the ultimate remediation alternatives undertaken at the site. The time frame for remediation is currently estimated to range from 6 to 10 years. Muskegon, Michigan -- Aerojet and its two inactive Cordova Chemical subsidiaries (Cordova) have been involved in litigation regarding a former Cordova facility in Muskegon, Michigan, where the EPA has conducted an RI/FS. The United States District Court for the Western District of Michigan previously ruled that Aerojet and Cordova were liable with a former owner/operator of the site for remediation at the facility. Separately, the State of Michigan Court of Claims previously ruled that the State of Michigan is obligated to indemnify Cordova for remediation costs which it incurs at the site. These rulings have been appealed to the Sixth Circuit United States Court of Appeals and the Michigan Court of Appeals, respectively. Aerojet and Cordova expect to prevail on these appeals. On a related matter, in May 1993 the U.S. EPA terminated, without resolution, two orders issued in 1990 and 1991 to Cordova and other parties to perform site remediation. Final remediation costs for groundwater and soils cannot presently be determined, but could range from $50 million to $100 million, depending on the remediation methods ultimately required. Furthermore, the Company believes that most of the remediation costs will be paid by the former owner/operator and that its $6 million reserve along with probable insurance recoveries of approximately $9 million will be adequate to cover the Company's costs and expenses associated with this matter. Toledo, Ohio -- In 1992, the Company signed a Consent Decree with the State of Ohio relative to the remediation of PCBs at its formerly owned Toledo, Ohio facility. A remediation plan for the removal of the PCBs under the Consent Decree was submitted to the State for review in January 1994. The Company believes that its established reserves of $4 million will be adequate to cover all future costs and expenses associated with this matter. San Gabriel Valley Basin, California -- Aerojet's Azusa facility is one of a large number of potentially responsible parties (PRPs) in the portion of the San Gabriel Valley Superfund Site known as the Baldwin Park Operable Unit (BPOU). Regulatory action is proceeding on two tracks: specific site investigation and cleanup, supervised by the California Regional Water Quality Control Board under delegation from the EPA, and regional groundwater remediation, under the direct control of the EPA. Aerojet is conducting an investigation of its current and historical properties in Azusa pursuant to a work plan negotiated with the Regional Board and EPA. Also, the EPA has issued a groundwater remediation plan for the BPOU, estimated to cost $47 million in non-recurring costs and $4 to $5 million in annual operating expense. There have been no negotiations to date concerning allocation of potential remediation costs among PRPs and other parties. Aerojet's environmental response costs in the San Gabriel Basin are being allowed by the government in the pricing of Aerojet's contracts. As a result, management does not believe, on the basis of presently available information, that resolution of this matter will materially affect the consolidated financial condition of the Company. Additionally, Aerojet has filed suit against its insurers for recovery of such costs. Other Sites -- The Company is also currently involved, together with other companies, in 19 other sites on the National Priority List under the federal Comprehensive Environmental Response, Compensation, and Liability Act (Superfund) and 14 other non-Superfund sites. In many instances, the Company's liability and 25 28 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED its proportionate share of costs has not been determined largely due to uncertainties as to the nature and extent of the site conditions, the Company's involvement and potential recoveries from insurance and other sources. While government agencies frequently claim potentially responsible parties are jointly and severally liable at such sites, in the Company's experience, interim and final allocations of liability costs are generally made based on relative contributions of waste. The Superfund sites include such sites as Stringfellow (California); Organic Chemical (Michigan); Summit National (Ohio); Hardage/Criner (Oklahoma); Industrial Excess (Ohio); and Solvent Recovery Service of New England (Connecticut). The non-Superfund sites include such sites as Westbury (New York); Four County Landfill (Indiana); and Delta Chemical (Pennsylvania). The Company's allocated share of investigation and remediation costs at a number of these sites has not yet been determined. Based on the Company's previous experience, its allocated share has been minimal, in many instances less than 1 percent. The Company, for example, was able to settle 4 sites in 1993 for less than $200,000. The Company has reserves of $12 million as of November 30, 1993 which it believes are sufficient to cover its best estimate of the environmental remediation costs at these other sites. ENVIRONMENTAL SUMMARY In regard to the sites discussed above, excluding Sacramento, management does not believe, on the basis of presently available information, that resolution of these matters will materially affect the consolidated financial condition of the Company. The effect of resolution of these matters on results of operations cannot be predicted due to the uncertainty concerning both the amount and timing of future expenditures and future results of operations. OTHER LEGAL MATTERS The Company and its subsidiaries are subject to various legal actions, governmental investigations, and proceedings relating to a wide range of matters in addition to those discussed above. In the opinion of management, after reviewing the information which is currently available with respect to such matters and consulting with the Company's counsel, any liability which may ultimately be incurred with respect to these additional matters will not materially affect the consolidated financial condition of the Company. The effect of these matters on results of operations cannot be predicted because any such effect depends on both future results of operations and the amount and timing of the resolution of such matters. NOTE O -- BUSINESS SEGMENT INFORMATION GenCorp Automotive designs and produces original equipment components and systems for the domestic, transplant and foreign automotive industries in Vehicle Sealing, Vibration Control and Reinforced Plastics. Specifically, these products include extruded rubber for vehicle body and window sealing, molded rubber for vibration control components and reinforced plastic body panels for passenger cars and trucks. Aerojet designs, develops and manufactures propulsion systems, defense electronics and ordnance products for the Department of Defense and National Aeronautics and Space Administration. Its three businesses are Propulsion, Electronic Systems and Ordnance. GenCorp Polymer Products manufactures specialty polymers and engineered plastics for consumers and industry. The segment is a leading producer of polymer-based products and operates five businesses: Designed Plastics, Plastic Films, Wallcovering, Penn Racquet Sports and Latex. The principal markets include the paper industry, residential and commercial construction and the sporting goods industry, as well as varied consumer and industrial markets that demand a broad range of thermoplastic products. GenCorp sales in 1993, 1992 and 1991 to the United States government and its agencies (principally the Department of Defense) totaled $847 million, $984 million and $1,108 million, respectively, and were generated almost entirely by the Aerojet segment. Sales to General Motors, primarily by GenCorp Automotive, of $250 million in 1993, $218 million in 1992 and $193 million in 1991 were at least 10 percent of the Company's net sales. 26 29 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- CONTINUED Segment operating profit represents net sales less applicable costs, expenses and provision for restructuring and unusual items relating to operations. Segment operating profit excludes corporate income and expenses, provisions for recapitalization/restructuring and unusual items, interest expense and income taxes. Segment operating profit increased 18 percent or $18 million in 1993 from $103 million in 1992. Excluding a provision for restructuring of $22 million, 1992 segment operating profit increased $14 million or 13 percent. Segment operating profit decreased at Aerojet while improving at both the Automotive and Polymer Products segments. The 1992 provision for restructuring was $22 million, approximately $14 million after tax, or $.45 per share, and related to costs associated with the restructuring of the Reinforced Plastics division within the Automotive segment. Identifiable assets are those assets that are used by the business segments and exclude corporate assets consisting principally of cash and marketable securities, certain investments and headquarters' fixed assets. Sales and identifiable assets of the Company's foreign operations, as well as export sales to unaffiliated customers, were each less than 10 percent of the related consolidated amounts. Intersegment sales were not material. 27 30 GENCORP INC. BUSINESS SEGMENT INFORMATION
YEARS ENDED NOVEMBER 30, ---------------------------- 1993 1992 1991 ------ ------ ------ (DOLLARS IN MILLIONS) NET SALES Aerojet.......................................................... $ 872 $1,019 $1,142 GenCorp Automotive............................................... 514 436 368 GenCorp Polymer Products......................................... 519 482 483 ------ ------ ------ $1,905 $1,937 $1,993 ------ ------ ------ SEGMENT OPERATING PROFIT (LOSS) Aerojet.......................................................... $ 53 $ 71 $ 75 GenCorp Automotive............................................... 21 9 (5) GenCorp Polymer Products......................................... 47 45 41 Restructuring and unusual items.................................. -- (22) -- ------ ------ ------ Segment Operating Profit............................... 121 103 111 Interest expense................................................. (36) (46) (52) Corporate other income and expense, net.......................... -- (3) 6 Corporate expenses............................................... (15) (17) (16) ------ ------ ------ Income before income taxes............................. $ 70 $ 37 $ 49 ------ ------ ------ ASSETS Aerojet.......................................................... $ 489 $ 498 $ 514 GenCorp Automotive............................................... 270 243 263 GenCorp Polymer Products......................................... 282 232 214 ------ ------ ------ Identifiable Assets.................................... 1,041 973 991 Marketable securities, cash and other Corporate assets........... 123 158 122 ------ ------ ------ Total assets........................................... $1,164 $1,131 $1,113 ------ ------ ------ CAPITAL EXPENDITURES Aerojet.......................................................... $ 20 $ 29 $ 42 GenCorp Automotive............................................... 28 27 31 GenCorp Polymer Products......................................... 18 39 19 Corporate........................................................ 1 1 1 ------ ------ ------ $ 67 $ 96 $ 93 ------ ------ ------ DEPRECIATION Aerojet.......................................................... $ 40 $ 47 $ 48 GenCorp Automotive............................................... 19 19 16 GenCorp Polymer Products......................................... 13 10 9 Corporate........................................................ 2 3 4 ------ ------ ------ $ 74 $ 79 $ 77 ====== ====== ======
28 31 GENCORP INC. QUARTERLY FINANCIAL DATA (UNAUDITED)
THREE MONTHS ENDED ---------------------------------------------------- FEBRUARY 28 MAY 31 AUGUST 31 NOVEMBER 30 ----------- ------ --------- ----------- (DOLLARS IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS) 1993 Net sales....................................... $ 401.5 $492.3 $ 482.1 $ 529.2 ------- ------ ------- ------- Gross profit.................................... 58.9 79.0 63.2 73.4 ------- ------ ------- ------- Income before income taxes...................... 10.2 29.6 12.9 16.9 ------- ------ ------- ------- Net income...................................... $ 6.1 $ 17.8 $ 7.7 $ 11.2 ------- ------ ------- ------- - ---------------------------------------------------------------------------------------------------- Net income per share of common stock Primary....................................... $ .19 $ .56 $ .25 $ .35 Fully Diluted................................. .19 .49 .24 .32 - ---------------------------------------------------------------------------------------------------- Common stock price range -- high................ 13 1/8 13 3/8 17 3/8 17 -- low................. 10 1/8 11 5/8 12 3/8 13 7/8
THREE MONTHS ENDED ---------------------------------------------------- FEBRUARY 29 MAY 31 AUGUST 31 NOVEMBER 30 ----------- ------ --------- ----------- (DOLLARS IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS) 1992 Net sales....................................... $ 461.4 $499.6 $ 452.2 $ 523.5 ------- ------ ------- ------- Gross profit.................................... 60.7 78.8 61.1 76.3 ------- ------ ------- ------- Income before income taxes...................... 4.1 23.0 8.3 2.2(A) ------- ------ ------- ------- Net income...................................... $ 2.2 $ 13.6 $ 4.9 $ 1.4 ------- ------ ------- ------- - ---------------------------------------------------------------------------------------------------- Net income per share of common stock............ $ .07 $ .43 $ .15 $ .05 - ---------------------------------------------------------------------------------------------------- Common stock price range -- high................ 14 3/4 15 5/8 14 7/8 13 1/2 -- low................. 9 1/4 12 7/8 12 1/4 8 7/8
- --------------- (A) Includes pretax provision of $21.7 million for the restructuring of the Reinforced Plastics division. CAPITAL STOCK The common stock is listed on the New York and Chicago Stock Exchanges. At December 31, 1993, there were approximately 15,600 holders of record of the Company's common stock. During 1993, 1992 and 1991, the Company paid quarterly cash dividends on common stock of $.15 per share. 29 32 GENCORP INC. SUMMARY OF SELECTED FINANCIAL DATA
YEARS ENDED NOVEMBER 30, ------------------------------------------------------------- 1993 1992 1991 1990 1989 1988 ------ ------ ------ ------ ------ ------ (DOLLARS IN MILLIONS, EXCEPT PER-SHARE AND RATIO DATA) NET SALES Aerojet........................................ $ 872 $1,019 $1,142 $ 878 $1,034 $1,056 GenCorp Automotive............................. 514 436 368 436 433 358 GenCorp Polymer Products....................... 519 482 483 461 471 477 ------ ------ ------ ------ ------ ------ $1,905 $1,937 $1,993 $1,775 $1,938 $1,891 SEGMENT OPERATING PROFIT (LOSS) Aerojet........................................ $ 53 $ 71 $ 75 $ 65 $ 92 $ 93 GenCorp Automotive............................. 21 9 (5) 23 10 28 GenCorp Polymer Products....................... 47 45 41 37 39 39 Restructuring and unusual items................ -- (22) -- 29 (52) (12) ------ ------ ------ ------ ------ ------ $ 121 $ 103 $ 111 $ 154 $ 89 $ 148 OPERATIONS Income from continuing operations.............. $ 43 $ 22 $ 32 $ 51 $ 8 $ 55 Income from discontinued operations............ -- -- -- 12 202 12 Cumulative effect on prior years of an accounting change............................ -- -- -- -- -- 3 ------ ------ ------ ------ ------ ------ Net income............................ $ 43 $ 22 $ 32 $ 63 $ 210 $ 70 PER SHARE OF COMMON STOCK Income from continuing operations.............. $ 1.35 $ .70 $ 1.00 $ 1.60 $ .25 $ 1.72 Income from discontinued operations............ -- -- -- .39 6.36 .37 Cumulative effect on prior years of an accounting change............................ -- -- -- -- -- .10 ------ ------ ------ ------ ------ ------ Net income (primary)........................... $ 1.35 $ .70 $ 1.00 $ 1.99 $ 6.61 $ 2.19 Net income (fully diluted)..................... $ 1.24 $ .70 $ 1.00 $ 1.99 $ 6.61 $ 2.19 Cash dividends paid............................ $ .60 $ .60 $ .60 $ .60 $ .60 $ .60 OPERATING RATIOS (CONTINUING OPERATIONS) Return on average assets employed.............. 9.3% 7.3% 9.4% 11.6% 5.9% 12.7% Assets employed turnover....................... 2.6x 2.7x 2.9x 2.3x 2.3x 2.7x Income from continuing operations to net sales........................................ 2.3% 1.1% 1.6% 2.9% .4% 2.9% GENERAL Capital expenditures........................... $ 67 $ 96 $ 93 $ 79 $ 111 $ 122 Depreciation................................... 74 79 77 74 70 63 Total assets................................... 1,164 1,131 1,113 1,078 1,270 1,230 Long-term debt................................. 416 344 355 345 496 674
30 33 REPORT OF INDEPENDENT AUDITORS Shareholders and Board of Directors of GenCorp Inc. We have audited the accompanying consolidated balance sheets of GenCorp Inc. as of November 30, 1993 and 1992, and the related consolidated statements of income, shareholders' equity, and cash flows for each of the three years in the period ended November 30, 1993. Our audits also included the financial statement schedules listed in the index at Item 14(a). These financial statements and schedules are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits. We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of GenCorp Inc. at November 30, 1993 and 1992, and the consolidated results of its operations and cash flows for each of the three years in the period ended November 30, 1993, in conformity with generally accepted accounting principles. Also, in our opinion, the related financial statement schedules, when considered in relation to the basic financial statements taken as a whole, present fairly in all material respects the information set forth therein. As discussed in Note N to the consolidated financial statements, Aerojet-General Corporation, a wholly owned subsidiary of GenCorp Inc., and Cordova Chemical Company, a wholly owned subsidiary of Aerojet, have been subject to environmental litigation arising from discharges of chemicals in past years at Aerojet's Sacramento, California facility. Eventual liabilities of Aerojet relating to this matter cannot be reasonably estimated at this time. ERNST & YOUNG Akron, Ohio January 24, 1994 31 34 PART III ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT Information with respect to nominees who will stand for election as a director of the Company at the March 30, 1994 Annual Meeting of Shareholders is set forth on pages 2 and 3 of the Company's 1994 Proxy Statement and is incorporated herein by reference. Information with respect to directors of the Company whose terms extend beyond the March 30, 1994 Annual Meeting of Shareholders is set forth on pages 3 and 4 of the Company's 1994 Proxy Statement and is incorporated herein by reference. Information with respect to compliance with Section 16(a) of the Exchange Act is set forth on page 5 of the Company's 1994 Proxy Statement and is incorporated herein by reference. Also, see Executive Officers of the Registrant on pages 6 and 7 of this report. ITEM 11. EXECUTIVE COMPENSATION Information regarding executive compensation is set forth on pages 8 through 17 of the Company's 1994 Proxy Statement and is incorporated herein by reference. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT Information regarding the security ownership of certain beneficial owners and management is set forth on pages 5 and 6 of the Company's 1994 Proxy Statement and is incorporated herein by reference. ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Information regarding certain transactions and employment arrangements with management is set forth on pages 13 and 14 of the Company's 1994 Proxy Statement and is incorporated herein by reference. PART IV ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K (a)(1) and (2) FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES A list of financial statements and financial statement schedules is set forth in a separate section of this report beginning on page GC-1. (a)(3) LISTING OF EXHIBITS An index of exhibits begins on page -i-of this report. (b) REPORTS ON FORM 8-K No reports on Form 8-K were filed during the quarter ended November 30, 1993. (c) EXHIBITS The response to this portion of Item 14 is set forth in a separate section of this report immediately following the Exhibit Index. (d) FINANCIAL STATEMENT SCHEDULES The financial statement schedules are set forth in a separate section of this report beginning on page GC-3. 32 35 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. GENCORP INC. February 17, 1994 By /s/ C. R. ENNIS ----------------------------------- C. R. Ennis, Vice President Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
SIGNATURE TITLE DATE - ---------------------------------------- --------------------------------- ------------------- /s/ A. W. REYNOLDS Chairman of the Board and Chief February 21, 1994 - ---------------------------------------- Executive Officer A. W. Reynolds /s/ J. B. YASINSKY President and Chief Operating February 18, 1994 - ---------------------------------------- Officer; Director J. B. Yasinsky /s/ D. M. STEUERT Vice President and Chief February 21, 1994 - ---------------------------------------- Financial Officer D. M. Steuert /s/ F. J. LUCKSINGER Vice President and Controller February 18, 1994 - ---------------------------------------- F. J. Lucksinger * Director February 17, 1994 - ---------------------------------------- R. K. Jaedicke * Director February 17, 1994 - ---------------------------------------- P. X. Kelley * Director February 17, 1994 - ---------------------------------------- R. D. Kunisch * Director February 17, 1994 - ---------------------------------------- J. Lafontant-Mankarious * Director February 17, 1994 - ---------------------------------------- J. M. Osterhoff * Director February 17, 1994 -------------------------------------- P. J. Phoenix * Director February 17, 1994 - ---------------------------------------- R. B. Pipes * Director February 17, 1994 - ---------------------------------------- H. A. Shaw III * Director February 17, 1994 - ---------------------------------------- J. R. Stover *Signed by the undersigned as attorney-in-fact and agent for the Directors indicated. /s/ E. R. DYE February 17, 1994 - ---------------------------------------- E. R. Dye
33 36 ANNUAL REPORT ON FORM 10-K ITEM 14(A)(1)(2) AND (3), (C) AND (D) LIST OF FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES FINANCIAL STATEMENT SCHEDULES EXHIBIT INDEX CERTAIN EXHIBITS FISCAL YEAR ENDED NOVEMBER 30, 1993 GENCORP INC. FAIRLAWN, OHIO 44333-3300 37 GENCORP INC. ITEM 14(A)(1) AND (2) INDEX TO FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES
PAGE NUMBER ------- (1) FINANCIAL STATEMENTS: The following consolidated financial statements of GenCorp Inc. are included in Item 8: Consolidated Statement of Income for the years ended November 30, 1993, 1992 and 1991 12 Consolidated Balance Sheet at November 30, 1993 and 1992 13 Consolidated Statement of Cash Flows for the years ended November 30, 1993, 1992 and 1991 14 Consolidated Statement of Shareholders' Equity for the years ended November 30, 1993, 1992 and 1991 15 Notes to Consolidated Financial Statements 16 (2) FINANCIAL STATEMENT SCHEDULES:
The following consolidated financial statement schedules of GenCorp Inc. are included in Item 14(d):
PAGE NUMBER ------ Schedule V -- Property, Plant and Equipment................................ GC-3 Schedule VI -- Accumulated Depreciation, Depletion and Amortization of Property, Plant and Equipment................................ GC-4 Schedule IX -- Short-Term Borrowings........................................ GC-5 Schedule X -- Supplementary Income Statement Information................... GC-6
All other schedules are omitted because they are inapplicable, not required by the instructions or the information is included in the consolidated financial statements or notes thereto. GC-1 38 CONSENT OF INDEPENDENT AUDITORS Shareholders and Board of Directors GenCorp Inc. We consent to the incorporation by reference in the Prospectuses constituting part of GenCorp Inc.'s Registration Statements No. 33-61928, 33-28056 and 2-98730 on Form S-8, Post Effective Amendment No. 1 to Registration Statements No. 2-80440 and 2-83133 on Form S-8, and Post Effective Amendment No. 4 to Registration Statement No. 2-66840 on Form S-8 of our report dated January 24, 1994, with respect to the consolidated financial statements and schedules of GenCorp Inc. included in this Annual Report (Form 10-K) for the year ended November 30, 1993. ERNST & YOUNG Akron, Ohio February 18, 1994 GC-2 39 SCHEDULE V GENCORP INC. PROPERTY, PLANT AND EQUIPMENT FOR THE YEARS ENDED NOVEMBER 30, 1993, 1992 AND 1991 (DOLLARS IN MILLIONS)
RECLASSI- FICATIONS BALANCE AT AND BALANCE BEGINNING ADDITIONS RETIRE- TRANSFERS - AT END CLASSIFICATION OF PERIOD AT COST MENTS ADD/(DEDUCT) OF PERIOD - ----------------------------------- ---------- --------- ------ ------------ --------- YEAR ENDED NOVEMBER 30, 1993 Land............................... $ 35 $-- $ -- $ -- $ 35 Buildings and building equipment... 300 15 (14) 2 303 Machinery and equipment............ 867 93 (35) -- 925 Construction in progress........... 58 (18) -- (4) 36 ------ --- ----- ---- ------- $1,260 $90(A) $(49) $ (2)(B) $ 1,299 ====== === ==== ==== ======= YEAR ENDED NOVEMBER 30, 1992 Land............................... $ 34 $ 1 $ -- $ -- $ 35 Buildings and building equipment... 283 18 (1) -- 300 Machinery and equipment............ 834 61 (26) (2) 867 Construction in progress........... 42 16 -- -- 58 ------ --- ----- ---- ------- $1,193 $96 $(27) $ (2)(B) $ 1,260 ====== === ==== ==== ======= YEAR ENDED NOVEMBER 30, 1991 Land............................... $ 32 $ 2 $ -- $ -- $ 34 Buildings and building equipment 264 18 -- 1 283 Machinery and equipment 791 70 (31) 4 834 Construction in progress 46 3 (6) (1) 42 ------ --- ----- ---- ------- $1,133 $93 $(37) $ 4(B) $ 1,193 ====== === ==== ==== =======
- --------------- Notes: (A) Includes $23 of assets acquired through the purchase of Reneer Films Corp. (B) Currency translation adjustments and other. GC-3 40 SCHEDULE VI GENCORP INC. ACCUMULATED DEPRECIATION, DEPLETION AND AMORTIZATION OF PROPERTY, PLANT AND EQUIPMENT FOR THE YEARS ENDED NOVEMBER 30, 1993, 1992 AND 1991 (DOLLARS IN MILLIONS)
ADDITIONS CHARGED RECLASSI- TO COSTS FICATIONS BALANCE AT AND EX- AND BALANCE BEGINNING PENSES RETIRE- TRANSFERS - AT END DESCRIPTION OF PERIOD (A) MENTS ADD/(DEDUCT) OF PERIOD - ----------------------------------- ---------- --------- ------ ------------ --------- YEAR ENDED NOVEMBER 30, 1993 Buildings and building equipment... $ 164 $12 $(14) $ (1) $ 161 Machinery and equipment............ 557 62 (29) 5 595 ------- ---- ----- ---- ------- $ 721 $74 $(43) $ 4(B) $ 756 ======= ==== ===== ==== ======= YEAR ENDED NOVEMBER 30, 1992 Buildings and building equipment... $ 152 $12 $ -- $ -- $ 164 Machinery and equipment............ 507 67 (26) 9 557 ------- ---- ----- ---- ------- $ 659 $79 $(26) $ 9(B) $ 721 ======= ==== ===== ==== ======= YEAR ENDED NOVEMBER 30, 1991 Buildings and building equipment... $ 141 $11 $ -- $ -- $ 152 Machinery and equipment............ 464 66 (27) 4 507 ------- ---- ----- ---- ------- $ 605 $77 $(27) $ 4(B) $ 659 ======= ==== ===== ==== =======
- --------------- Notes: (A) Depreciation for financial reporting is computed principally by accelerated methods for Aerojet and by the straight-line method for the remainder of the Company. Useful lives for depreciation range from 15 to 50 years for buildings and building equipment and 3 to 25 years for machinery and equipment. (B) Currency translation adjustments and other. GC-4 41 SCHEDULE IX GENCORP INC. SHORT-TERM BORROWINGS FOR THE YEARS ENDED NOVEMBER 30, 1993, 1992 AND 1991 (DOLLARS IN MILLIONS)
MAXIMUM AVERAGE WEIGHTED WEIGHTED AMOUNT AMOUNT AVERAGE BALANCE AT AVERAGE OUTSTANDING OUTSTANDING INTEREST RATE CATEGORY OF AGGREGATE END OF INTEREST DURING THE DURING THE DURING THE SHORT-TERM BORROWINGS PERIOD RATE PERIOD (A) PERIOD (B) PERIOD (B) - ----------------------------------- ---------- -------- ----------- ----------- ------------- YEAR ENDED NOVEMBER 30, 1993 Notes payable...................... $ 22 3.9% $25 $10 3.7% YEAR ENDED NOVEMBER 30, 1992 Notes payable...................... $ -- -- $40 $ 8 4.7% YEAR ENDED NOVEMBER 30, 1991 Notes payable...................... $ -- -- $49 $14 6.8%
- --------------- Notes: (A) At month end. (B) Daily weighted-average method used. GC-5 42 SCHEDULE X GENCORP INC. SUPPLEMENTARY INCOME STATEMENT INFORMATION FOR THE YEARS ENDED NOVEMBER 30, 1993, 1992 AND 1991 (DOLLARS IN MILLIONS) CHARGED TO COSTS AND EXPENSES
YEARS ENDED NOVEMBER 30, ---------------------- ITEM 1993 1992 1991 ---- ---- ---- ---- Maintenance and repairs.................................... $59 $60 $59
- --------------- Note: Items otherwise required by this schedule are not presented because they are less than one percent of consolidated revenues or included in this Annual Report (Form 10-K). GC-6 43 EXHIBIT INDEX
TABLE EXHIBIT EXHIBIT ITEM NO. DESCRIPTION LETTER -------- ----------- ------- 3. ARTICLES OF INCORPORATION AND BY-LAWS The Amended Articles of Incorporation of GenCorp Inc., as amended as of December 7, 1987, were filed as Exhibit A to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1988 (File No. 1-1520), and are incorporated herein by reference. (17 pages) The Code of Regulations of GenCorp Inc., as amended November 25, 1987, were filed as Exhibit B to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1988 (File No. 1-1520), and are incorporated herein by reference. (16 pages) 4. INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES Amended and Restated Rights Agreement (with exhibits) dated as of December 7, 1987 between GenCorp Inc. and Morgan Shareholder Services Trust Company as Rights Agent was filed as Exhibit D to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1987 (File No. 1-1520), and is incorporated herein by reference. (86 pages) Information relating to the Company's long-term debt is set forth in Note I of this report, which information is incorporated herein by reference. The Indenture, dated as of July 1, 1992, between GenCorp and the Bank of New York as trustee relating to the Company's $115,000,000 8% Convertible Subordinated Debentures due August 1, 2002 and the form of Debenture were filed as Exhibits A and B to the Company's Quarterly Report on Form 10-Q for the quarter ended August 31, 1992 (File No. 1-1520) and are incorporated herein by reference. (107 pages) Instruments defining the rights of holders of other long-term debt are not filed herewith since no such single debt item exceeds 10 percent of consolidated assets. The Company agrees, however, to furnish a copy of any such agreement or instrument to the Commission upon request. 10. MATERIAL CONTRACTS An Employment Agreement dated August 4, 1984 between the Company and A.W. Reynolds, Chairman and Chief Executive Officer and a Director of the Company was filed as Exhibit A to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1984 (File No. 1-1520), and is incorporated herein by reference. (3 pages) An Employment Agreement dated October 15, 1993 between the Company and J. B. Yasinsky, President and Chief Operating Officer of the Company. (4 pages).................................................. A Form of Severance Agreement granted to executive officers of the Company to provide for payment of an amount equal to 125 percent of base salary multiplied by a factor of 3 if their employment should terminate for any reason other than death, disability, willful misconduct or retirement within three years after a change in control, as such term is defined in such agreement was filed as Exhibit A to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1990 (File No. 1-1520), and is incorporated herein by reference. (12 pages) Benefits Restoration Plan for Salaried Employees of GenCorp Inc. and Certain Subsidiary Companies as amended and restated effective December 1, 1986, was filed as Exhibit G to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1987 (File No. 1-1520), and is incorporated herein by reference. (6 pages)
i 44
TABLE EXHIBIT EXHIBIT ITEM NO. DESCRIPTION LETTER -------- -------------------------------------------------------------------- ------- pages)Amendment to the GenCorp Inc. and Participating Subsidiaries Stock Incentive Compensation Plan, effective as of April 5, 1987, was filed as Exhibit H to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1987 (File No. 1-1520), and is incorporated herein by reference. (6 pages) Information relating to the Deferred Bonus Plan of GenCorp Inc. is contained in Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 2-83133 dated April 18, 1986 and is incorporated herein by reference. (16 pages) Amendment to the Deferred Bonus Plan of GenCorp Inc. effective as of April 5, 1987, was filed as Exhibit I to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1987 (File No. 1-1520), and is incorporated herein by reference. (3 pages) GenCorp Inc. Deferred Compensation Plan for Nonemployee Directors effective January 1, 1992 was filed as Exhibit A to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1991 (File No. 1-1520) and is incorporated herein by reference. (18 pages) GenCorp Inc. Long-Term Incentive Program effective January 27, 1993 was filed as Exhibit A to the Company's Annual Report on Form 10-K for the fiscal year ended November 30, 1992 (File No. 1-1520) and is incorporated herein by reference. (24 pages) GenCorp Inc. 1993 Stock Option Plan effective March 31, 1993 was filed as Exhibit 4.1 to Form S-8 Registration Statement No. 33-61928 dated April 30, 1993 and is incorporated herein by reference. (11 pages) 11. STATEMENT RE COMPUTATION OF PER SHARE EARNINGS (1 page)............................................................ B 21. SUBSIDIARIES OF THE REGISTRANT Listing of Subsidiaries (1 page).................................... C 23. CONSENTS OF EXPERTS Consent of Ernst & Young is contained on page GC-2 of this Form 10-K and is incorporated herein by reference. 24. POWER OF ATTORNEY Powers of Attorney executed by R. K. Jaedicke, P. X. Kelley, R. D. Kunisch, J. Lafontant-Mankarious, J. M. Osterhoff, R. B. Pipes, P. J. Phoenix, H. A. Shaw III, and J. R. Stover, Directors of the Company. (9 pages).................................................. D The Company will supply copies of any of the foregoing exhibits to any shareholder upon receipt of a written request addressed to GenCorp Inc., 175 Ghent Road, Fairlawn, Ohio 44333-3300 -- Attention: Secretary, and payment of $1 per page to help defray the costs of handling, copying and return postage.
ii EX-10 2 GENCORP EXHIBIT A 1 EXHIBIT A October 15, 1993 Mr. John B. Yasinsky 503 West Manor Drive Pittsburgh, PA 15238 Dear John: I am delighted that you will be joining GenCorp. We are excited about you and Marlene becoming part of the GenCorp family. This will confirm our understanding concerning, and further define, the terms and conditions of your employment with GenCorp. 1. You will initially be employed as the President and Chief Operating Officer ("President"). In this capacity, you will devote your full time and efforts to the performance of those duties customarily and usually performed by the President, subject at all times to the direction of the Chairman and Chief Executive Officer ("Chairman") and the Board of Directors ("Directors"). At their next meeting, the Directors will elect you as a corporate officer and as a Director. 2. We anticipate that the Directors will elect you Chairman and Chief Executive Officer ("Chairman") of GenCorp at or before the July 1995 meeting of Directors. If the Directors remove you as President prior to such meeting or fail to elect you Chairman at or before such meeting, or if, after electing you as Chairman, remove you from such position prior to your attaining age 65, you may elect to terminate your employment and receive the termination payment specified in paragraph 3 and the supplemental pension specified in paragraph 8. The preceding sentence notwithstanding, you shall not be entitled to either the termination payment specified in paragraph 3 or the supplemental pension specified in paragraph 8 if the Directors decide to remove you as either President or Chairman or not to elect you Chairman for or due to cause. As used herein, "cause" means any willful (i) failure to follow any instruction or policy of GenCorp, the Directors, or the Chairman, (ii) commission of any felony, (iii) falsification of any company document or (iv) act committed to provoke dismissal. 3. The term of your employment will be indefinite in duration and, therefore, subject to termination at will by notice from you or GenCorp. However, if GenCorp elects to terminate your employment before you reach age 65 for any reason except cause or you elect to terminate your employment due to any decision of the Directors which is specified in paragraph 2 and which is not based on or due to cause, GenCorp will pay you an amount equal to two times the sum of (i) your annual base salary at the time of such termination and (ii) the year-end bonus which GenCorp paid to you in respect of the last fiscal year preceding such termination; provided that you execute and deliver to GenCorp a release of all claims and/or causes of action that arise during or in connection with the termination of your employment, except claims (i) to the termination payment specified in this paragraph 3, the supplemental pension specified in paragraph 8, and any other payment herein specified, and (ii) under any stock option awarded to you or any employee compensation and/or benefit plan of GenCorp. 4. GenCorp will pay you as President annual compensation comprising a base salary and a year-end bonus, which amounts are subject to adjustment on an annual basis. Your initial annual base salary as President will be $460,000 per year and will be payable in twenty-four semi-monthly installments in accordance with GenCorp's normal pay practices. Additionally, your initial year-end bonus for fiscal year 1994 will be not less than $200,000, which will be payable by February 1, 1995 in accordance with GenCorp's normal pay practices. 5. After commencement of your employment with GenCorp, GenCorp will pay you the following amounts: (a) a one-time payment of $300,000 to compensate you for loss of any bonus payment by Westinghouse Electric, Inc. ("Westinghouse"). Such payment will be reduced by the amount of any 2 bonus payment which you receive from Westinghouse for services performed in 1993. Such payment, if any, will be made prior to March 1, 1994. (b) A one-time payment of $500,000 to compensate you for any other payments, benefits, or entitlements which you may lose or forfeit under any employee compensation or benefit plan or program of Westinghouse, including but not limited to any bonus, long-term incentive compensation, pension, stock option or other plan of Westinghouse. Such payment will be made promptly after commencement of your employment with GenCorp. The payments specified in this paragraph 5 are in lieu of any and all rights, benefits, and entitlements which you may lose or forfeit due to the termination of your employment with Westinghouse and GenCorp will have no obligation to make any other payment to you in respect thereof. 6. Concurrent with commencement of your employment with GenCorp, the Directors will grant you an award of 100,000 shares under GenCorp's 1993 Stock Option Plan. Such award will be effective as of the first day of your employment and the share price will be based on the market price of GenCorp's shares on the date of the award as provided in the 1993 Stock Option Plan. 7. As President, you will be eligible to participate in GenCorp's Long Term Incentive Program (a copy of which is enclosed herewith) and you will be deemed to be a participant therein during the entire 1993-1995 performance period. As you know, each performance period comprises three consecutive years. If GenCorp achieves specified performance targets, you would be entitled to receive an incentive payment equal to approximately 30% of your average annual compensation during the performance period. However, such payments cannot exceed 60% of your average annual compensation during any such period. 8. You will be entitled to participate in GenCorp's Pension Plan for Salaried Employees ("Pension Plan") and, in addition, you will be eligible to receive a supplemental pension as set forth in this paragraph. (a) For purposes of calculating your supplemental pension, you shall be credited with 30 years of service upon commencement of your employment and you will receive one additional year of credit for each year of service that you complete following commencement of your employment with GenCorp. (b) Your supplemental pension will be an annual amount which is determined as a single-life annuity commencing at age 65 in the manner provided in the Pension Plan and is equal to the number of your total years of credited service multiplied by 1.47% of your average annual compensation, reduced by the sum of any and all pension payments (determined for this purpose as the actuarial equivalent single-life annuity) (i) which GenCorp makes to you or to which you are entitled under any other pension plan of GenCorp, whether qualified or non-qualified (including GenCorp's Benefits Restoration Plan), and (ii) which Westinghouse makes to you or to which you would be entitled under any pension plan of Westinghouse, whether qualified or non-qualified, assuming retirement at the same time as your retirement from GenCorp. For this purpose, "average annual compensation" means the sum of (x) one-fifth of the aggregate base salary paid to you during the 60 months (consecutive or non-consecutive) in the 120-month period prior to your retirement (including employment at Westinghouse), during which your base salary was the highest, plus (y) the average of your five highest year-end bonus payments in the 10-year period prior to your retirement (including employment at Westinghouse). (c) You shall be entitled to retire at any time after your sixty-second birthday without any reduction in the amount of your supplemental pension due to retirement prior to age 65. If you retire prior to age 62, the amount of your supplemental pension shall be reduced by 0.4 percent for each month by which your pension commencement date precedes your sixty-second birthday and in a manner consistent with the Pension Plan. A-2 3 (d) Your supplemental pension will be payable monthly at the same time and in the same manner that pensions are paid under the Pension Plan. Each monthly payment shall be 1/12 of the annual amount determined pursuant to subparagraphs (b) and (c). Additionally, you may elect payment of the supplemental pension in the form of (i) a single-sum amount or (ii) a 100% or 50% joint and survivor annuity, with your wife as the joint annuitant. Either of such optional forms of payment shall be the actuarial equivalent of the monthly pension amount, calculated in accordance with the terms and procedures applicable under the Pension Plan. (e) If you die before electing a joint and survivor annuity, whether or not you have attained age 62, GenCorp will pay the supplemental pension to your surviving wife for her life, calculated as if you had attained age 62, retired, and elected a joint and 100% survivor annuity on the last day of the month prior to your death. (f) If you become totally disabled and unable to perform your duties as President or Chairman, GenCorp shall pay you a monthly disability benefit equal to 60% of your base monthly salary until you reach age 62, at which time you shall be eligible to retire and receive the supplemental pension under the terms of this paragraph. However, such disability benefit shall be reduced by the amount of any disability benefit payments which you are entitled to receive under federal laws until such time as you retire. 9. You will be eligible to participate in GenCorp's Benefit Restoration Plan which is designed to restore benefits under the Pension Plan and the GenCorp Savings Plan which a participant otherwise would lose as a result of limitations imposed by the Internal Revenue Code. 10. GenCorp will pay or reimburse you for relocation expenses which you incur pursuant to GenCorp's Relocation Program, including assistance on the sale of your residence, transportation of household goods, and purchase of a residence in the greater Akron/Cleveland area. A copy of this Program is being sent to you under separate cover. 11. You will be entitled to four weeks paid vacation during each year of your employment. Any unused vacation may not be carried forward nor will you be entitled to receive pay in lieu of any unused vacation. In 1993, the period December 27 through December 31 will be company-paid holidays. If necessary to meet your previous family commitment, additional vacation days will be available to you during this holiday period. 12. During your employment, GenCorp will provide for your business and personal use a U.S. manufactured automobile which you may select. Personal use will be calculated in accordance with GenCorp's established practice and treated as income to you. 13. GenCorp has entered into an agreement with AYCO to provide individual financial counseling for its corporate officers. This arrangement will be available to you on a cost-sharing basis. If you elect to participate, your cost will be 10% of the annual fees charged by AYCO. The first year total charge is estimated to be $10,080. AYCO is currently charging $5,040 for subsequent years. You will have an imputed income liability for the company-paid 90%. You may be able to offset this expense if you are able to itemize deductions for these financial counseling services. Consult your personal tax advisor for information regarding deductibility. 14. Building and maintaining business relationships with community leaders, customers, and suppliers is an important function which the President is expected to perform. GenCorp will pay or reimburse you for membership fees and dues at a local country club for your business and personal use. In addition, GenCorp will reimburse you for the one-time cost of purchasing from Westinghouse the surety bond for the Pittsburgh Field Club membership. All such payments and reimbursements will be treated as personal income to you in accordance with and as required by law. 15. GenCorp will provide you the opportunity to receive a physical examination at the Greenbrier Clinic or any other qualified medical center that you may select. The frequency and extent of any such examination will be pursuant and subject to the provisions of GenCorp's Executive Physical Directive. A-3 4 16. You will be eligible to participate in the GenCorp Savings Plan which provides matching contributions equal to 75% of the first six percent of a participant's contributions from base salary and year-end bonus compensation. The Savings Plan allows supplemental contributions from eligible compensation on a pre-tax and after-tax basis. The contribution rate may be limited by certain restrictions imposed by the Internal Revenue Code. All matching contributions vest immediately. 17. In addition to the above-mentioned employee benefit plans, you will be eligible to participate in the other employee benefit plans which GenCorp has established for its salaried employees (in each case, subject to and in accordance with the provisions of the applicable plan), including the following: - Comprehensive Health Care - Dental Care - Life Insurance - Supplemental Group Universal Life Insurance - Long Term Disability Insurance Nothing herein will be deemed to preclude GenCorp from changing or terminating any employee benefit plan, program, or practice applicable to you and other employees or require GenCorp to employ you for any specific period of time. Participation in some of these plans is voluntary and requires employee contributions. 18. The provisions herein contained are in lieu of a severance agreement of the type which GenCorp heretofore has entered into with its executive officers to provide certain severance payments in the event of any "change in control" of GenCorp (as defined in such severance agreement). However, if any such change in control occurs after commencement of your employment, you may exercise any right of termination provided in paragraph 2, if any. Additionally, if GenCorp breaches any material obligation hereunder after any such change in control, you may terminate this agreement and receive the termination payment specified in paragraph 2 and the supplemental pension specified in paragraph 8. If the foregoing meets with your understanding and approval, please acknowledge by executing and returning to me the enclosed copy. Following that, I will submit this agreement to the Directors as soon as possible. Upon their approval, the agreement will then become effective. Yours truly, GENCORP INC. By --------------------------------- A. William Reynolds Enclosure Approved and accepted this day of , 1993. - ---------------------------- John B. Yasinsky copy: H. A. Shaw, Chairman of the Nominating Committee A-4 EX-11 3 GENCORP EXHIBIT B 1 EXHIBIT B GENCORP INC. COMPUTATION OF EARNINGS PER COMMON SHARE
YEARS ENDED NOVEMBER 30, ---------------------------- 1993 1992 1991 ------ ------ ------ EARNINGS (Dollars in Millions) Net income for Primary Earnings Per Share.................. $42.8 $22.1 $31.7 Tax Affected Interest Expense Applicable to 8% Convertible Subordinated Debentures.................................. 5.5 1.9 -- ------ ------ ------ Net Income for Fully Diluted Earnings Per Share............ $48.3 $24.0 $31.7 ===== ===== ===== SHARES (In Thousands) Weighted Average Number of Common Shares Outstanding for Primary Earnings Per Share............................... 31,730 31,729 31,730 Assuming Conversion of 8% Convertible Subordinated Debentures............................................... 7,158 2,470 -- ------ ------ ------ Weighted Average Number of Common Shares Outstanding for Fully Diluted Earnings Per Share......................... 38,888 34,199 31,730 ====== ====== ====== EARNINGS PER SHARE Primary Earnings Per Share................................. $1.35 $.70 $1.00 Fully Diluted Earnings Per Share........................... $1.24 $.70 $1.00
EX-21 4 EXHIBIT 1 EXHIBIT C LISTING OF GENCORP INC. SUBSIDIARIES(1)
STATE OR PERCENTAGE JURISDICTION OF OF VOTING INCORPORATION OWNERSHIP --------------- ---------- Aerojet-General Corporation(2)...................................... Ohio 100. Aerojet Ordnance Tennessee, Inc................................... Tennessee 100. Chemical Construction Corporation................................. Delaware 100. General Applied Science Laboratories, Inc......................... New York 100. GenCorp International............................................... Ohio 100. Penn Racquet Sports Co. (Ireland)................................. Ireland 100. Penn Europe GmbH.................................................. Germany 100. GenCorp Polymer Products S.A.R.L.................................. France 100. GenCorp Canada Inc.................................................. Canada 100. RKO General, Inc.................................................... Delaware 100. RKO Hotel Group, Inc................................................ Delaware 100. RKO Hotels, Inc..................................................... Delaware 100. Genco Insurance Limited............................................. Bermuda 100. GenCorp Export Corporation.......................................... Virgin Islands 100. GenCorp Investment Management, Inc.................................. Ohio 100. GKK Automotive Co., Ltd............................................. Ohio 60. GT Automotive Co., Ltd.............................................. Ohio 60. -----
- --------------- (1) GenCorp Inc. conducts business using the names GenCorp, GenCorp Automotive and GenCorp Polymer Products. (2) Aerojet-General Corporation conducts business using the names Aerojet ASRM Division, Aerojet Electronic Systems Division, Aerojet Ordnance Division and Aerojet Propulsion Division. EX-24 5 EXHIBIT 1 EXHIBIT D POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ R.K. JAEDICKE -------------------------- R.K. Jaedicke Dated: January 26, 1994 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ P.X. KELLEY ---------------------------- P.X. Kelley, Director Dated: January 26, 1994 D-2 3 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ R.D. KUNISCH ----------------------------- R.D. Kunisch, Direcor Dated: January 26, 1994 D-3 4 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ J. LAFONTANT-MANKARIOUS ----------------------------------- J. Lafontant-Mankarious, Director Dated: January 26, 1994 D-4 5 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ J.M. OSTERHOFF ------------------------------ J.M. Osterhoff, Director Dated: January 26, 1994 D-5 6 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ P.J. PHOENIX ----------------------------- P.J. Phoenix, Director Dated: January 26, 1994 D-6 7 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ R.B. PIPES ---------------------------- R.B. Pipes, Director Dated: January 26, 1994 D-7 8 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ H.A. SHAW ---------------------------- H.A. Shaw, Director Dated: January 28, 1994 D-8 9 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned Director of GenCorp Inc. hereby constitutes and appoints C. R. Ennis and E. R. Dye, and each of them (each with full power to act alone), his true and lawful attorneys-in-fact and agents, will full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of GenCorp Inc. for the fiscal year ended November 30, 1993 on his behalf, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact or agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney expires March 1, 1994. /s/ J.R. STOVER ------------------------------ J.R. Stover, Director Dated: January 26, 1994 D-9 -----END PRIVACY-ENHANCED MESSAGE-----